<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1093967</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Regulatory effects of oral microbe on intestinal microbiota and the illness</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Yanbei</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2091448"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Zhengyi</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2057019"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Peng</surname>
<given-names>Xian</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/461444"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases</institution>, <addr-line>Chengdu, Sichuan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Feng Chen, Peking University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Tomoko Hanawa, Kyorin University, Japan; Santosh K. Ghosh, Case Western Reserve University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xian Peng, <email xlink:href="mailto:pengx@scu.edu.cn">pengx@scu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Extra-intestinal Microbiome, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1093967</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Lu, Li and Peng</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Lu, Li and Peng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Over the past decade, the association between oral health, intestinal microbiota, and systemic diseases has been further validated. Some oral microbial species have been isolated from pathological intestine mucosa or feces and identified as biomarkers for intestinal diseases. A small proportion of oral microbiome passes through or colonizes the lower gastrointestinal tract, even in healthy individuals. Opportunistic pathogens from the oral cavity may expand and participate in the occurrence and progression of intestinal diseases when the anatomical barrier is disrupted. These disruptors interact with the intestinal microbiota, disturbing indigenous microorganisms, and mucosal barriers through direct colonization, blood circulation, or derived metabolite pathways. While interacting with the host&#x2019;s immune system, oral-derived pathogens stimulate inflammation responses and guide the transition of the intestinal microenvironment from a healthy state to a pre-disease state. Therefore, the oral-gut microbiome axis sheds light on new clinical therapy options, and gastrointestinal tract ecology balance necessitates simultaneous consideration of both oral and gut microbiomes. This review summarizes possible routes of oral microbes entering the intestine and the effects of certain oral bacteria on intestinal microbiota and the host&#x2019;s immune responses.</p>
</abstract>
<kwd-group>
<kwd>oral microbe</kwd>
<kwd>intestinal microbe</kwd>
<kwd>gut diseases</kwd>
<kwd>microbiota</kwd>
<kwd>immunity</kwd>
<kwd>oral-gut axis</kwd>
</kwd-group>
<contract-num rid="cn001">32070120</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="147"/>
<page-count count="13"/>
<word-count count="6564"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>For human beings, the slow-flowing and weakly acidic colon dominate the largest, densest, and most diverse microbial community, with a capacity of up to 100 billion to one trillion cells per milliliter of intestinal contents, acting as a highly efficient bioreactor (<xref ref-type="bibr" rid="B113">Sender et&#xa0;al., 2016</xref>). Functional heterogeneity of each intestinal segment determines the diversity of microbial populations in different anatomical regions, and various intestinal microbiotas sustain intestinal physiological development and epithelial homeostasis. Thus, intestinal microbiota dysbiosis is deeply correlate with gut diseases such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colorectal cancer (CRC), and even systemic metabolism or inflammatory diseases (e.g., rheumatism, obesity, etc.) (<xref ref-type="bibr" rid="B101">Priya et&#xa0;al., 2022</xref>). Gut microbes-derived metabolite pathways disrupt intestinal homeostasis and proceed to intestinal diseases <italic>via</italic> regulating the production of short-chain fatty acids (SCFAs) and trimethylamine, or distantly signal to parenteral organs and the immune system through releasing microbes or metabolites into the bloodstream (<xref ref-type="bibr" rid="B83">McPherson et&#xa0;al., 2021</xref>).</p>
<p>The oral and intestine are anatomically contiguous in the gastrointestinal (GI) tract, which provides chances for expanded oral pathobionts being ingested and translocated to the gut, suggesting the role of oral microbes in regulating intestinal microecology. However, many current studies separately focus on these two regions in an organ-specific manner without considering microbial translocation. The oral contains various microhabitats that are exposed or not exposed to the air. Tooth surfaces, tongue, mucous membrane, and gums are habitats of aerobe microbes whereas periodontal pockets mainly resident facultative anaerobic and anaerobic microbes, potentially act as complementary reservoirs for opportunistic enteric pathogens. However, the prerequisites for ectopic colonization of oral microbes are harsh. The majority of oral pathobionts are inactivated by gastric acidity, bile acid, colonization resistance of native microbiotas, and the immune system. As a validation, proton pump inhibitors (PPIs) users and achlorhydria patients exhibit an abnormal increase in gut colonization by oral pathobionts (<xref ref-type="bibr" rid="B55">Jackson et&#xa0;al., 2016</xref>). In recent years, experimental and sequencing research have successively revealed biological homologies between oral and intestinal flora, indicating the potential value of the oral-gut axis in precise diagnosis, effective treatment, and prognosis of gut diseases (<xref ref-type="bibr" rid="B96">Park et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B12">Bao et&#xa0;al., 2022</xref>). For instance, saliva could be used as a biomarker to investigate gastrointestinal status conveniently and non-invasively (<xref ref-type="bibr" rid="B130">Wang et&#xa0;al., 2021b</xref>).</p>
<p>Hundreds of proteins and peptides released by oral microbes could be metabolized into a variety of bioactive by-products, many of which are toxic (<xref ref-type="bibr" rid="B13">Barbour et&#xa0;al., 2022</xref>). Consequently, these metabolites possibly explain the ability that oral-to-gut microbial transmissions to shape or reshape the intestinal microbial ecosystem and eventually modulate the pathogenesis. In the intestine, oral microorganisms participate in various immunoactivity and inflammatory pathways. Saliva translocated mice intestine model shows altered cytokines, chemokines, and tight junction protein compositions, indicating the induced intestinal inflammation and enhanced mucosa permeability (<xref ref-type="bibr" rid="B122">Tsuzuno et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B12">Bao et&#xa0;al., 2022</xref>). The damaged intestinal mucosa increases antigen exposure, which indirectly activates immune cells and upregulates systemic inflammatory factors. In parallel, the ectopic oral pathobionts, rather than gut-resident microbes, activate the periodontist-induced Th17-skewed T cells that are imprinted with gut tropism (<xref ref-type="bibr" rid="B63">Kitamoto et&#xa0;al., 2020</xref>). Hence, regarding clinical therapy, oral microbes shall be considered synchronously and comprehensively with intestinal native microbes in designing treatment regimens.</p>
<p>It is not fully understood the exact oral microbes that influence gut microbiota and the mechanism of these intruders participating in intestinal diseases, further elucidations are still required. As the oral microbiome can exhibit a stable state of at least 3 months, and the gut microbiome for up to 5 years, the crosstalk between oral and intestinal microecology is pathological and clinically valuable (<xref ref-type="bibr" rid="B39">Faith et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B131">Wei et&#xa0;al., 2021</xref>). In this review, we highlighted the interconnections and translocation route between the oral cavity and the intestine, the immune-resistant strategy from the host, and the mechanism of the oral microorganism interacting with the intestinal ecology to provide a reference for the research frontier concerning the impact of oral microbes on intestinal microbiota.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Pathways of oral microorganisms entering the intestine</title>
<sec id="s2_1">
<label>2.1</label>
<title>Enteral route</title>
<p>Normal humans produce 0.75-1.5L saliva per day, which contains a considerable number of microbes. In mice experiments that establish oral microbial infection through oral administration or gavage of the saliva from periodontitis patients, an abnormal enrichment of oral pathobionts that were confirmed as secondary components of the salivary microbiota was detected in mice&#x2019;s intestines (<xref ref-type="bibr" rid="B8">Atarashi et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B12">Bao et&#xa0;al., 2022</xref>). For human beings, most oral species (including core Soral taxa, <italic>Streptococcus, Veillonella, Actinomyces</italic>, and <italic>Haemophilus</italic>) that result in endogenous infection emerged in the GI tract in health and disease status, with high levels of variation across individuals (<xref ref-type="bibr" rid="B112">Schmidt et&#xa0;al., 2019</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Transient physiological bacteremia triggered by periodontitis and dental procedures permits oral pathogens to stretch themselves systemically. Patients with periodontitis possess a less diverse gut microbiota, and higher possession of oral taxa in the intestine gives rise to more serious gut inflammation (<xref ref-type="bibr" rid="B78">Lourenvarsigmao et al., 2018</xref>). To tolerate the inactivation of stomach acid and bile acid, these unexpected &#x201c;visitors&#x201d; are expected to be highly acid-resistant. Moreover, <italic>P. gingivalis</italic> and <italic>F. nucleatum</italic> can be parasitic on dendritic cells or macrophages and disrupt extraoral tissues (<xref ref-type="bibr" rid="B21">Carrion et al., 2012</xref>; <xref ref-type="bibr" rid="B137">Xue et al., 2018</xref>). Oral microbes, including <italic>P. gingivalis</italic>, <italic>Actinomyces</italic>, <italic>Streptococcus</italic>, and <italic>Treponema denticola</italic>, have been confirmed as sources of non-oral organs in a colonizing manner (<xref ref-type="bibr" rid="B42">Figuero et al., 2014</xref>; <xref ref-type="bibr" rid="B145">Zhang et al., 2021</xref>; <xref ref-type="bibr" rid="B35">Deppe et al., 2022</xref>). Chronic oral infection establishes <italic>F. nucleatum</italic> colonization that significantly induces systemic humoral IgG and IgM antibody responses (<xref ref-type="bibr" rid="B126">Velsko et al., 2015</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1093967-g001.tif"/>
</fig>
<sec id="s2_1_1">
<label>2.1.1</label>
<title>Duodenum</title>
<p>High-throughput DNA sequencing of oral, duodenal, and pancreatic samples reveals distinct strain-level clustering patterns for each anatomical region and microbiome overlaps between them (<xref ref-type="bibr" rid="B14">Barlow et&#xa0;al., 2021</xref>). This similarity is further extended in the context of GI diseases, and absolute loads of ectopic colonized microbes are positively correlate with more severe GI symptoms. Dyspepsia patients&#x2019; duodenum components behave oral-like, including organisms from the HACEK group, <italic>Klebsiella</italic>, <italic>Escherichia</italic>, <italic>Enterococcus</italic>, and <italic>Clostridium</italic>, replace the ordinary strict anaerobes (<xref ref-type="bibr" rid="B14">Barlow et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B28">Chung et&#xa0;al., 2021</xref>). Moreover, automatically connected as the gate towards the pancreas, the oral bacterium in the duodenum may be capable of entering the pancreas. For instance, the periodontal microbes (<italic>Porphyromonas gingivalis</italic> and <italic>Aggregatibacter actinomycetemcomitans</italic>) have been proven positively related to pancreatic cancer risk (<xref ref-type="bibr" rid="B40">Fan et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B87">Nagata et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B119">Tan et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s2_1_2">
<label>2.1.2</label>
<title>Intestinal canal</title>
<p>The oral microflora owns the highest level of variation and the most diverse library of unique sequences, whereas this diversity gradually decreases from the oral to the distal gut, indicating that the microbiome undergoes selective pressure (<xref ref-type="bibr" rid="B107">Richardson et&#xa0;al., 2020</xref>). If successfully reaching the intestine, these intruders are usually pathogenic. In the intestine, oral-derived microbiotas create an inflammatory and immunosuppressive microenvironment suitable for tumorigenesis. It is detected the existence of oral-originated bacteria (<italic>Fusobacterium nucleatum, P. gingivalis</italic>, and <italic>Parvimonas micra</italic>) in CRC tissues, while butyrate-producing and anti-inflammatory microbes that originally lived in the intestine decreased correspondingly (<xref ref-type="bibr" rid="B45">Gao et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B146">Zhao et&#xa0;al., 2021</xref>). Ectopic oral microbes also participate in the pathogenic process of IBS and IBD (<xref ref-type="bibr" rid="B76">Liu et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B15">Baumgartner et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B136">Xia et&#xa0;al., 2021</xref>). Sequencing and endoscopies of IBS and ulcerative colitis (UC) patients&#x2019; intestines reveal a unique and characteristic ecological dysbiosis of dense bacterial biofilms and several biofilm-forming microbial species of dental plaques (<xref ref-type="bibr" rid="B15">Baumgartner et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B136">Xia et&#xa0;al., 2021</xref>). According to the sequencing of diseased full-thickness colon specimens including the neuromuscular region, the dominance of putative oral pathogens such as <italic>Firmicutes</italic> (<italic>Streptococcus, Staphylococcus, Peptostreptococcus</italic>) and <italic>Fusobacteria</italic> (<italic>Fusobacterium</italic>) potentially modulate colon motility (<xref ref-type="bibr" rid="B36">Dinakaran et&#xa0;al., 2018</xref>). Additionally, despite the shortage of research illustrating oral microbes colonizing in IBS patients&#x2019; intestines, the altered composition of oral microbes correlates with the severity of IBS (<xref ref-type="bibr" rid="B43">Fourie et&#xa0;al., 2016</xref>).</p>
</sec>
<sec id="s2_1_3">
<label>2.1.3</label>
<title>Accessory organs of the digestive tract</title>
<p>The liver is one of the most-affected organs by biological network fluctuations, and the gut-liver axis is crucial in linking intestinal microbes and extraintestinal organs (<xref ref-type="bibr" rid="B4">Albillos et&#xa0;al., 2020</xref>). There are two possible clues for the involvement of oral microbes in the liver-gut axis. During periodontitis, the liver is constantly exposed to pathogenic factors from the oral, periodontitis-related systemic hypo-inflammation and chemokine potentially affect hepatic metabolic pathways. Both fecal and salivary microbiota have independent prognostic value for cirrhosis progress, specifically, <italic>via</italic> impaired salivary defense (<xref ref-type="bibr" rid="B141">Yonezawa et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B57">Jia et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B110">Saboo et&#xa0;al., 2022</xref>). The subgingival microbiota of cirrhotic patients consists of an uncommon bacterial community, indicating that its origin is from ecological dysregulation by immune system impairment (<xref ref-type="bibr" rid="B56">Jensen et&#xa0;al., 2018</xref>). Moreover, gut microbiota dysbiosis induced by the enteral translocation of periodontopathic bacteria weakens the mucous barrier, thus promoting the enterohepatic transfer of hepatotoxins and enterobacteria (<xref ref-type="bibr" rid="B69">Kuraji et&#xa0;al., 2021</xref>). <italic>Via</italic> disturbing intestinal metabolic and immune pathways, <italic>Porphyromonas gingivalis</italic> accelerates the progression of non-alcoholic fatty liver disease (NAFLD) (<xref ref-type="bibr" rid="B5">Albuquerque-Souza and Sahingur, 2022</xref>; <xref ref-type="bibr" rid="B128">Wang et&#xa0;al., 2022</xref>). Primary sclerosing cholangitis (PSC) with or without coexisting IBD is another typical manifestation of the altered gut-liver axis (<xref ref-type="bibr" rid="B109">Ruhlemann et&#xa0;al., 2019</xref>). Even in the early stages, PSC patients&#x2019; stool and mucosa significantly enrich oral pathogenic bacteria such as <italic>Streptococcus</italic>, <italic>Veillonella</italic>, and <italic>Actinomyces</italic> (<italic>Streptococcus salivarius</italic> is an independent predictor of liver-related three-year mortality) (<xref ref-type="bibr" rid="B109">Ruhlemann et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B57">Jia et&#xa0;al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Hematogenous route</title>
<p>Particularly for periodontitis and periapical inflammation patients, transient physiological bacteremia triggered by tooth extraction and periodontal procedures permits oral pathogens to stretch themselves systemically <italic>via</italic> the circulatory system (<xref ref-type="bibr" rid="B92">Olsen and Yamazaki, 2019</xref>)(<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). For severe periodontitis, the subgingival plaque has direct access to the damaged periodontal pocket, bacteria are more likely to infiltrate periodontal blood vessels and gingival epithelium in the context of the increased mucosa permeability, through which, <italic>P. gingivalis</italic> and <italic>F. nucleatum</italic> can be parasitic on dendritic cells or macrophages and disrupt extraoral tissues (<xref ref-type="bibr" rid="B21">Carrion et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B137">Xue et&#xa0;al., 2018</xref>). It is widely acknowledged the linkage (not causation) between periodontal disease and atherosclerotic vascular disease. Oral microbes, including <italic>P. gingivalis</italic>, <italic>Actinomyces</italic>, <italic>Streptococcus</italic>, and <italic>Treponema denticola</italic>, have been confirmed as sources of infected heart valves, atherosclerotic plaques, and rheumatic heart valves (<xref ref-type="bibr" rid="B42">Figuero et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B145">Zhang et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B35">Deppe et&#xa0;al., 2022</xref>). In this way, pathogens and their metabolites may be disseminated to the intestine similarly. Periodontal patients possess a less diverse gut microbiota, and higher possession of oral taxa in the intestine, which gives rise to more serious gut inflammation (<xref ref-type="bibr" rid="B78">Lourenvarsigmao et&#xa0;al., 2018</xref>). A retrospective analysis of individuals&#x2019; blood samples indicates that patients with <italic>F. nucleatum</italic> or <italic>Streptococcus pepticus</italic> bacteremia are more likely to suffer from subsequent colorectal cancer (<xref ref-type="bibr" rid="B70">Kwong et&#xa0;al., 2018</xref>). For clinical CRC diagnosis, plasma is more advantageous than stool in sensitivity and holds a more unique and heterogeneous microbial community, the vast majority of circulating bacterial DNA could retrospect to the gastrointestinal tract and the oral cavity (<xref ref-type="bibr" rid="B135">Xiao et&#xa0;al., 2021</xref>).</p>
<p>However, the accurate location of oral microbes and the probability of colonization in the distal intestine remain controversial. Precise amplicon sequence variants analysis accomplished by Armin Rashidi et&#xa0;al. excluded a significant distinction of microorganisms between oral and gut (66 healthy adults from two countries), indicating more clinical pathologic examinations are still required (<xref ref-type="bibr" rid="B105">Rashidi et&#xa0;al., 2021</xref>). Vasapolli et&#xa0;al.&#x2019; s sequencing regarding healthy subjects&#x2019; saliva, mucosa, and stool samples from each segment of the GI tract displayed an approximate absence of major species of the upper GI tract in the lower GI tract (<xref ref-type="bibr" rid="B125">Vasapolli et&#xa0;al., 2019</xref>). Similarly, the correlation between oral taxa and pancreatic cancer did not present among an African-American population as previously speculated (<xref ref-type="bibr" rid="B97">Petrick et&#xa0;al., 2022</xref>). <italic>Via</italic> symbiotic analysis, Carr et&#xa0;al. discovered contrasting ARG-species correlations between saliva and stool samples (<xref ref-type="bibr" rid="B22">Carr et&#xa0;al., 2020</xref>). Whereas most 16S rRNA gene sequencing analyses only reliably classify taxa to the genus level and do not report species and strains usually. Using shotgun metagenomic sequencing, oral and gut bacterial communities show greater similarity than earlier studies suggested (<xref ref-type="bibr" rid="B34">de Cena et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B82">Maki et&#xa0;al., 2021</xref>). Moreover, diurnal variations, processing methods, race, and diet are irrelevant interference with measurement results, which requires further consideration in future studies (<xref ref-type="bibr" rid="B117">Superdock and Poole, 2022</xref>).</p>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Host&#x2019;s immune strategy for resisting translocation</title>
<p>The gingiva consists of epithelium, blood vessels, lymphatic vessels, etc., which provides a physical and chemical barrier to separate the external and the internal. However, periodontal tissue is highly susceptible to dysbiosis and inflammation induced by opportunistic pathogens that reside in gingival crevicular fluid and periodontal pockets. Pathological periodontal tissues activate immune responses as the regional accumulation of leukocytes and B cells and the increase of IL-1&#x3b2;, IL-6, and TNF (<xref ref-type="bibr" rid="B79">Lu et&#xa0;al., 2016</xref>). Lipopolysaccharide (LPS) produced by oral microbes activates the toll-like receptors (TLR)-nuclearfactorkappa-B (NF-&#x3ba;B) pathway, a key factor for innate and adaptive immune responses. Moreover, it is widely acknowledged the correlation between periodontitis and systemic low-grade inflammation (e.g., Diabetes, rheumatoid arthritis, IBD, obesity, and cirrhosis) (<xref ref-type="bibr" rid="B32">D'Aiuto et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B67">Kroese et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B85">Moskovitz et&#xa0;al., 2021</xref>). During periodontitis, systemic immunity feeds back on the pathological periodontal region and affects the intestine nonspecifically. Chronic oral infection establishes ectopic oral <italic>F. nucleatum</italic> colonization in the intestine and significantly induces systemic humoral IgG and IgM antibody responses (<xref ref-type="bibr" rid="B126">Velsko et&#xa0;al., 2015</xref>). In mice models that are orally administrated with saliva pathogens, endotoxemia and intestinal dysbiosis are induced (<xref ref-type="bibr" rid="B64">Kobayashi et&#xa0;al., 2020</xref>). Consistent with this, periodontal therapy effectively proves the dysbiosis in stool and saliva, endotoxin, and salivary or serum inflammation factors in cirrhotics (<xref ref-type="bibr" rid="B11">Bajaj et&#xa0;al., 2018</xref>). Long-term chronic inflammation even results in an immunization training effect. Myeloid skewing of hematopoietic progenitor cell differentiation which guides the expression of various microbial product receptors, if chronically activated, potentially sustains chronicity of inflammatory pathologies (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) (<xref ref-type="bibr" rid="B49">Hajishengallis and Chavakis, 2021</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Experimental studies of oral microbe in intestinal ecology.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left">Year</th>
<th valign="top" rowspan="2" align="center">Study objects</th>
<th valign="top" rowspan="2" align="center">Experimental treatment</th>
<th valign="top" colspan="2" align="center">Microecology vatiations</th>
<th valign="top" rowspan="2" align="center">16S rRNA Sequencing region</th>
</tr>
<tr>
<th valign="top" align="center">Phylum</th>
<th valign="top" align="center">Family/Other classification methods</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">2021</td>
<td valign="top" align="left">C57BL/6J mice</td>
<td valign="top" rowspan="2" align="left">
<italic>P. gingivalis</italic> infection</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&#x3b2;-diversity varied</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2021</td>
<td valign="top" align="left">diabetes mice</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Prevotellaceae</italic>&#x2191;</td>
<td valign="top" align="left">(metagenomic analysis)</td>
</tr>
<tr>
<td valign="top" align="left">2017</td>
<td valign="top" align="left">C57BL/6 mice</td>
<td valign="top" align="left">
<italic>P.gingivalis</italic> infection-vs western diet</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">&#x3b1;-diversity&#x2193;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2014</td>
<td valign="top" align="left">C57BL/6N mice</td>
<td valign="top" rowspan="3" align="left">
<italic>P.gingivalis</italic> infection (W83)-vs placebo control</td>
<td valign="top" align="left">
<italic>Bacteroidales</italic>&#x2191; (excluding <italic>P. gingivalis</italic>)</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">V5-V6</td>
</tr>
<tr>
<td valign="top" align="left">2015</td>
<td valign="top" align="left">C57BL/7N mice</td>
<td valign="top" align="left">
<italic>Bacteroidetes</italic>&#x2191;, <italic>Firmicutes</italic>&#x2193;</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2018</td>
<td valign="top" align="left">C57BL/8N mice</td>
<td valign="top" align="left">
<italic>Deferribacteres</italic>&#x2191;, <italic>Bacteroidetes</italic>&#x2193;</td>
<td valign="top" align="left">
<italic>Deferribacteriaceae</italic>, <italic>Gemellaceae</italic>, <italic>Clostridiaceae</italic>&#x2191;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2019</td>
<td valign="top" align="left">streptozotocin-induced diabetic C57BL/6J mice and wild-type mice</td>
<td valign="top" align="left">
<italic>P.gingivalis</italic> infection-vs placebo control</td>
<td valign="top" align="left">
<italic>Deferribacteres</italic>&#x2191;</td>
<td valign="top" align="left">
<italic>Lactobacillus</italic>, <italic>Turicibacter</italic>&#x2193;</td>
<td valign="top" align="left">V1-V2</td>
</tr>
<tr>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">C57BL/6 mice</td>
<td valign="top" align="left">
<italic>S. mitis, S. salivarius, P. gingivalis</italic> or <italic>P. nigrescen</italic> oral infection</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Staphylococcus</italic>, <italic>Bacteroides</italic>&#x2191;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">wild-type BALB/cJ mice</td>
<td valign="top" align="left">Kanamycin sulfate administered and <italic>P.gingivalis</italic> infection</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Acholeplasmataceae</italic>&#x2191;</td>
<td valign="top" align="left">V3&#x2013;V4 and ITS1</td>
</tr>
<tr>
<td valign="top" align="left">2019</td>
<td valign="top" align="left">germ-free mice</td>
<td valign="top" align="left">human saliva transplantation</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">*<italic>Streptococcus</italic>, <italic>Veillonella</italic>, <italic>Haemophilus</italic>, <italic>Fusobacterium</italic>, <italic>Trichococcus Actinomyces</italic>&#x2191;</td>
<td valign="top" align="left">V4-V5</td>
</tr>
<tr>
<td valign="top" align="left">2021</td>
<td valign="top" align="left">C57BL/6N mice</td>
<td valign="top" align="left">administered either vehicle, <italic>P. gingivalis</italic>, or <italic>P. intermedia</italic>
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Eubacterium fissicatena</italic>, <italic>Atopostipes Colidextribacter</italic>&#x2191;</td>
<td valign="top" align="left">/</td>
</tr>
<tr>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">germ-free mice</td>
<td valign="top" align="left">oral pathobionts or periodontal microbe infection</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">*<italic>Veillonella rogosae</italic>, <italic>Actinomyces naeslundii</italic>
</td>
<td valign="top" align="left">/</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">C57BL/6J mice</td>
<td valign="top" align="left">intraperitoneal administration of Pg-LPS</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>S24-7</italic>&#x2191;, <italic>Lachnospiraceae</italic>, <italic>Bacteroides</italic>, <italic>Lactobacillus</italic>&#x2191;</td>
<td valign="top" align="left">V3&#x2013;V4</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">C57BL/6 mice</td>
<td valign="top" rowspan="3" align="left">periodontitis individuals' saliva gavage</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Aerococcus Ruminococcus</italic>&#x2191;</td>
<td valign="top" align="left">/</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">C57BL6/J mice</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">*<italic>Porphyromonadaceae Fusobacterium</italic>
</td>
<td valign="top" align="left">V4-V5</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">C57BL/6NJcl (germ-free) mice</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">SKG mice</td>
<td valign="top" rowspan="2" align="left">periodontitis induction by <italic>P. gingivalis</italic>
</td>
<td valign="top" align="left">
<italic>Bacteroides</italic>&#x2191;, <italic>Firmicutes</italic>, <italic>Deferribacteres</italic>, <italic>Clostridiales</italic>&#x2193;</td>
<td valign="top" align="left">S24-7&#x2191;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">apoE mice</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Allobaculum</italic>, <italic>Akkermansia</italic>, <italic>Sutterella</italic>&#x2191;</td>
<td valign="top" align="left">V3&#x2013;V4</td>
</tr>
<tr>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">C57BL/6 J mice</td>
<td valign="top" align="left">chronic periodontitis induction</td>
<td valign="top" align="left">
<italic>Firmicutes</italic>, <italic>Verrucomicrobia</italic>, <italic>Acidobacteria</italic>&#x2191;, <italic>Tenericutes</italic>&#x2193;</td>
<td valign="top" align="left">
<italic>Dubosiella</italic>, <italic>Muribaculum</italic>, <italic>Butyricicoccus</italic> &#x2191;</td>
<td valign="top" align="left">V3-V4</td>
</tr>
<tr>
<td valign="top" align="left">2018</td>
<td valign="top" align="left">C57BL/6 J mice</td>
<td valign="top" align="left">endotoxemia by intravenous injection of P. gingivalis</td>
<td valign="top" align="left">
<italic>Tenericutes</italic>, <italic>Proteobacteria</italic>&#x2193;</td>
<td valign="top" align="left">
<italic>Alcaligenaceae</italic>, <italic>Erysipelotrichaceae</italic>&#x2191;, <italic>Dehalobacteriaceae</italic>, <italic>Ruminococcaceae</italic>&#x2193;</td>
<td valign="top" align="left">V3-V4</td>
</tr>
<tr>
<td valign="top" align="left">2017</td>
<td valign="top" align="left">CIA DBA/1J mice</td>
<td valign="top" align="left">
<italic>P.gingivalis</italic> OMT</td>
<td valign="top" align="left">
<italic>Firmicutes</italic>&#x2191;, <italic>Bacteroidetes</italic>&#x2193;</td>
<td valign="top" align="left">
<italic>Prevotella</italic>, <italic>Bacteroidetes</italic>&#x2193;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">induced-colitis C57BL/6 mice model</td>
<td valign="top" align="left">oral <italic>Candida albicans</italic> infection</td>
<td valign="top" align="left">
<italic>Bacteriodes</italic>, <italic>Proteobacteria</italic>&#x2191;</td>
<td valign="top" align="left">
<italic>Enterobacter</italic>, <italic>Pseudomonas</italic>&#x2191;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">C57BL/6 mice</td>
<td valign="top" align="left">
<italic>P. gingivalis</italic> infection-vs PBS control</td>
<td valign="top" align="left">
<italic>Acholeplasmataceae</italic>
</td>
<td valign="top" align="left">
<italic>Pyricularia pennisetigena</italic>, <italic>Alternaria alternata</italic>&#x2191;</td>
<td valign="top" align="left">(metagenomic analysis)</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">T1D germ-free mice</td>
<td valign="top" align="left">mixed saliva samples inoculation</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">*<italic>Klebsiella pneumoniae</italic>
</td>
<td valign="top" align="left">V3-V4</td>
</tr>
<tr>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">ligature-induced periodontitis model</td>
<td valign="top" align="left">/</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Klebsiella</italic>, <italic>Enterobacter</italic>&#x2191;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2021</td>
<td valign="top" align="left">BALB/c athymic nude mice</td>
<td valign="top" align="left">/</td>
<td valign="top" align="left">
</td>
<td valign="top" align="left">
<italic>Blautia</italic>, <italic>Lachnospiraceae</italic>, <italic>Streptococcus</italic> (CRC locus)&#x2191;</td>
<td valign="top" align="left">V4</td>
</tr>
<tr>
<td valign="top" align="left">2022</td>
<td valign="top" align="left">APPswe/PS1&#x394;E9 (PAP) transgenic mice</td>
<td valign="top" align="left">/</td>
<td valign="top" align="left">
<italic>Bacteroidetes</italic>&#x2191;, <italic>Firmicutes</italic>&#x2193;</td>
<td valign="top" align="left">
<italic>Sutterella</italic>&#x2191;, <italic>Lactobacillus</italic>&#x2193;</td>
<td valign="top" align="left">V3-V4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>(* composition variation of microbiota was detected).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The gut has physiologically formulated multiple strategies to resist colonization by non-native bacteria. Complete mucosa protection contains the joint efforts of symbiotic microbiota, surface liquids, and junctional components (<xref ref-type="bibr" rid="B19">Caballero and Pamer, 2015</xref>). <italic>Via</italic> the gingival-intestinal axis, the swallowed saliva transmits enzymes, effector cytokines bacteria, and bioactive inflammatory cell subsets (neutrophils, lymphocytes, and macrophages) to distant locations (<xref ref-type="bibr" rid="B18">Byrd and Gulati, 2021</xref>). Macrophages fulfill sentinel functions as the first responder for ectopic microbes (<xref ref-type="bibr" rid="B52">Hausmann et&#xa0;al., 2021</xref>). Cells of Paneth autonomously sense LPS <italic>via</italic> MyD88-dependent TLR, then stimulate antimicrobial cytokines and trigger the downstream NF-&#x3ba;B pathway, which subsequently regulates the production of Th17 cells or Tregs (LPS from <italic>P. gingivalis</italic> induces a stronger Th2 response while <italic>Klebsiella pneumoniae</italic> induces a stronger Th1 response) (<xref ref-type="bibr" rid="B123">Vaishnava et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B102">Qi et&#xa0;al., 2022</xref>). Proinflammatory pathogens and metabolites gradually predispose the gut to an inflammatory state, manifesting as an enhanced expression of IL-1, IL-6, TNF-&#x3b1;, and vascular endothelial growth factor (VEGF), stimulating the release of collagenase, prostaglandin, and thromboxane (<xref ref-type="bibr" rid="B3">Akdis, 2021</xref>) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). In IBD, whose major pathogenic processes involve the overreaction (hypersensitivity) of the immune response toward commensal intestinal bacteria, the mutation of the nucleotide-binding oligomerization domain 2 (NOD2) gene results in the reduction of antimicrobial peptides produced by Paneth cells (<xref ref-type="bibr" rid="B71">Larabi et&#xa0;al., 2020</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>To maintain ecological balance, intestinal protective elements resist extra-intestinal microbes in the oral-derived microbiome dysbiosis. In the intestine, the enteral translocation of periodontopathic bacteria brings about gut microbiota dysbiosis and intestinal inflammation, thus weakening the intestinal surface liquids and junctional components (<xref ref-type="bibr" rid="B88">Nakajima et al., 2015</xref>; <xref ref-type="bibr" rid="B41">Feng et al., 2020</xref>). While interacting with the host&#x2019;s immune system, via enteral route or hematogenous route, oral-derived pathogens regulate the constitution and transformation of immune cells, guiding the transition of the intestinal microenvironment from a healthy state to a pre-disease state. In regard to cell signaling pathways, cells of Paneth autonomously sense a series of oral metabolites via MyD88-dependent toll-like receptor (TLR), then stimulate antimicrobial cytokines and trigger the downstream NF-kB pathway, which subsequently regulates the production of a series of inflammatory cytokines (<xref ref-type="bibr" rid="B123">Vaishnava et al., 2008</xref>; <xref ref-type="bibr" rid="B102">Qi et al., 2022</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1093967-g002.tif"/>
</fig>
</sec>
<sec id="s4">
<label>4</label>
<title>Mechanisms of oral microbiome affecting intestinal microbiota</title>
<sec id="s4_1">
<label>4.1</label>
<title>Porphyromonas gingivalis</title>
<p>In general knowledge, <italic>P. gingivalis</italic> is a major pathogen for periodontitis and extensively involves in systemic diseases. To disrupt host-microbial homeostasis of the oral cavity, <italic>P. gingivalis</italic> only needs a microscopic colonization level (&lt;0.01% of the total microbiota presented) (<xref ref-type="bibr" rid="B50">Hajishengallis et&#xa0;al., 2011</xref>). Extracellular translocation of <italic>P. gingivalis</italic>-nucleotide-diphosphate-kinase enzyme (NDKs) promotes microbial molecules to disrupt cytoplasm and establishes continuous infection in mucosal epithelial tissues (<xref ref-type="bibr" rid="B7">Atanasova et&#xa0;al., 2016</xref>). In mice experiments, a series of symptoms appeared after <italic>P. gingivalis</italic> infection (oral administration, gavage, or intravenous injection), including endotoxemia, intestinal inflammation, and systemic hypo-inflammation (<xref ref-type="bibr" rid="B91">Ohtsu et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B59">Kashiwagi et&#xa0;al., 2021</xref>). Regarding the intestine, <italic>P. gingivalis</italic> infection gives rise to microbiome dysbiosis. It increases serum endotoxin levels, allowing opportunistic pathogens to colonize in the oral cavity and stimulating the overgrowth of commensal microbes in the intestine (generally upregulates <italic>Bacteroidetes</italic> and <italic>Deferribacteres</italic>, and downregulates <italic>Firmicutes</italic>) (<xref ref-type="bibr" rid="B88">Nakajima et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B91">Ohtsu et&#xa0;al., 2019</xref>). <italic>Pyricularia pennisetigena</italic> and <italic>Alternaria alternata</italic> positively correlated with <italic>P. gingivalis</italic> administration in the fungal community. Serum metabolites are modified correspondingly with microbial alteration, especially lipid and tryptophan metabolic pathways (<xref ref-type="bibr" rid="B26">Chen et&#xa0;al., 2022</xref>). In <italic>P. gingivalis</italic>-administered mice, the biosynthesis of phenylalanine, tyrosine, and tryptophan in the intestinal microbiota are upregulated, with alanine, glutamine, histidine, tyrosine, and phenylalanine in serum promoted considerably in the serum (<xref ref-type="bibr" rid="B60">Kato et&#xa0;al., 2018</xref>). In terms of mechanism, <italic>P. gingivalis</italic> and its metabolites (e.g., gingipains and extracellular vesicles) activate antigen-presenting cells, initiating intestinal inflammation and immune reactions. <italic>Via</italic> stimulating TLR2/4 and inducing Th17 cells, <italic>P. gingivalis</italic> and its metabolites heighten the mRNA expression of TNF-&#x3b1; and IL-1&#x3b2; in the colon (<xref ref-type="bibr" rid="B41">Feng et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B118">Tang et&#xa0;al., 2021</xref>). Regional inflammation impairs the permeability of the intestinal barrier, specifically, downregulates <italic>tjp-1</italic> and <italic>occludin</italic> gene expression, and decreases colic zonula occludens-1 (Zo-1) level (<xref ref-type="bibr" rid="B88">Nakajima et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B41">Feng et&#xa0;al., 2020</xref>). Next, the altered proinflammatory cytokines mentioned above modify methionine (Met) and homocysteine (Hcy) metabolism (i.e., 1-carbon metabolism), which potentially stimulates hyperhomocysteinemia (HHcy), another mechanism participating in intestinal dysbiosis (<xref ref-type="bibr" rid="B116">Stanisic et&#xa0;al., 2021</xref>). In terms of Th17 cells, a recent study reported a noticeable synergy between periodontal tissue and gut microbes. The intestinal translocation of <italic>P. gingivalis</italic> enhances Th17 cell differentiation, and mature Th17 cells systemically spread to peripheral immune tissue and then exacerbate intestinal inflammation (<xref ref-type="bibr" rid="B111">Sato et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B86">Nagao et&#xa0;al., 2022</xref>). Consistent with this, the Th17/Treg imbalance induced by disordered intestinal microbial metabolism directly generates NAFLD in <italic>P. gingivalis</italic> administration mice (<xref ref-type="bibr" rid="B140">Yao et&#xa0;al., 2022</xref>). Compared to normal individuals, CRC patients&#x2019; intestines are pathologically colonized with abnormally abundant <italic>P. gingivalis</italic>, whose infection gives rise to a poor CRC prognosis (<xref ref-type="bibr" rid="B45">Gao et&#xa0;al., 2021</xref>). <italic>Via</italic> activating NLRP3 inflammatory vesicles (activated hematopoietic NOD-like receptor protein 3 inflammasomes) <italic>in vitro</italic> and <italic>in vivo</italic>, <italic>P. gingivalis</italic> triggers low-grade systemic inflammation and intestinal dysbiosis, promoting CRC neoplasia progression (<xref ref-type="bibr" rid="B129">Wang et&#xa0;al., 2021a</xref>). Moreover, the peptidoglycan from <italic>P. gingivalis</italic> molecules induces programmed cell death 1 ligand 1 (PD-L1) up-regulation in colon carcinoma cells and mediates deep inhibition of T cells (involving activation of RIP2 and MAPK signaling pathways, and NOD1 and NOD2) (<xref ref-type="bibr" rid="B2">Adel-Khattab et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Fusobacterium nucleatum</title>
<p>
<italic>F. nucleatum</italic> normally resides in the intestine but increases synchronously with common oral microorganisms during CRC. 40% of the CRC patients detected identical <italic>F. nucleatum</italic> strains in both tumor tissue and saliva (<xref ref-type="bibr" rid="B65">Komiya et&#xa0;al., 2019</xref>). Moreover, successful periodontitis treatment reduces stool <italic>F. nucleatum</italic> levels (<xref ref-type="bibr" rid="B142">Yoshihara et&#xa0;al., 2021</xref>). Therefore, intestinal pathological <italic>F. nucleatum</italic> may derive from the oral. The continuum of its species and abundance in the GI tract could be an explanation. Transferring from saliva to the lower GI tract, the species diversity and abundance of <italic>F. nucleatum</italic> gradually dropped, indicating they resisted the selective stomach pressure (<xref ref-type="bibr" rid="B107">Richardson et&#xa0;al., 2020</xref>). Several <italic>F. nucleatum</italic> subspecies (<italic>nucleatum, animalis, vincentii, polymorphum</italic>) and potential new subspecies are isolated from the intestine of colorectal cancer patients, and the major encoding virulence factors for <italic>F. uncleatum</italic> showed evidence of horizontal gene transfer (<xref ref-type="bibr" rid="B120">Tran et&#xa0;al., 2022</xref>). Furthermore, intraperitoneal injection successfully established colonization of <italic>F. nucleatum</italic> in CRC tissue, which suggested the translocation of <italic>F. nucleatum</italic> through hematogenous route (<xref ref-type="bibr" rid="B1">Abed et&#xa0;al., 2020</xref>). Ponath et&#xa0;al. report FoxI, a conserved <italic>F. nucleatum</italic> oxygen-inducible picornavirus, acting as a post-transcriptional blocker of the major outer membrane porin FomA, is favorable for explicating how <italic>F. nucleatum</italic> colonizing in diverse segments in the intestine (<xref ref-type="bibr" rid="B98">Ponath et&#xa0;al., 2021</xref>).</p>
<p>In mucosal tissues, the adhered <italic>F. nucleatum</italic> promotes inflammation and stimulates immunoreaction. <italic>F. nucleatum</italic> and its outer membrane vesicles (OMVs) activate TLR/MyD88/NF-&#x3ba;B pathway, promoting the secretion of a series of proinflammatory cytokines, including IL-8, TNF, keratinocyte-derived chemokine (KC), IL-6, IFN-&#x3b3;, and monocyte chemoattractant protein-1 (MCP-1) (<xref ref-type="bibr" rid="B24">Chen et&#xa0;al., 2020b</xref>; <xref ref-type="bibr" rid="B38">Engevik et&#xa0;al., 2021b</xref>). The colonic structure and mucus layers are damaged and infiltrated with immune cells. When regarding UC, this inflammatory process involves a molecular network including caspase activation, recruitment domain 3 (CARD3), and IL-17F (<xref ref-type="bibr" rid="B20">Cao et&#xa0;al., 2020</xref>). In addition, the TLR4-dependent mechanism (TLR4/NF-&#x3ba;B/S100A9 axis and NF-&#x3ba;B/miR-1322/CCL20 axis) promotes the M2 polarization of macrophages (M2-M&#x3c6;) and immunosuppressive effect, suggesting that oral <italic>F. nucleatum</italic> evolves more powerful virulence after colonization (<xref ref-type="bibr" rid="B25">Chen et&#xa0;al., 2018</xref>). Another virulence factor <italic>Fusobacterium</italic> produced that participates in immune regulation is the Fap2 protein, which directly interacts with TIGIT, mediates NK cell and T cell inhibition, while T-cell regulates inflammatory factors IL-10, IL-1&#x3b2;, and IL-6 (<xref ref-type="bibr" rid="B48">Gur et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B75">Li et&#xa0;al., 2019</xref>). Regarding CRC, <italic>F. nucleatum</italic> and its main pathogenic factors (FadA (binding E-cadherin), Fap2 (a galactose-sensitive hemagglutinin and adhesin binding TIGHT receptors), RadD (autotransporter) and FomA) recruit tumor-infiltrating immune cells, generating tumor microenvironment and participating in immunosuppression and tumorigenesis (<xref ref-type="bibr" rid="B127">Walencik, 2022</xref>). <italic>F. nucleatum</italic> modifies colonic Th17 cell frequency and IL-17 expression recombinant free fatty acid receptor 2 (FFAR2)-dependently (<xref ref-type="bibr" rid="B17">Brennan et&#xa0;al., 2021</xref>). Moreover, it positively correlated with the expression of Wnt-&#x3b2;-catenin (activated by FadA&#x2500;E-cadherin) and REG I&#x3b1; signaling, both of which effectively promotes the proliferation of sessile serrated adenoma/polyp (<xref ref-type="bibr" rid="B108">Rubinstein et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B90">Nishimura et&#xa0;al., 2021</xref>). <italic>ENO1</italic> gene and ANGPTL4 protein enhance the high glycolysis of colorectal cancer cells, and these two regulatory mechanisms could be upregulated by <italic>F. nucleatum</italic> either, which further support <italic>F. nucleatum</italic> colonization and positively collated with poor prognosis (<xref ref-type="bibr" rid="B53">Hong et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B147">Zheng et&#xa0;al., 2021</xref>). Besides, it is a notable phenomenon in periodontal disease that a variety of bacteria, including <italic>F. nucleatum</italic> and <italic>P. gingivalis</italic>, mutually coordinate for coexistence. Presumably, this symbiosis continues to the intestine. In the intestine, <italic>F. nucleatum</italic> coexists with <italic>Clostridium</italic> through adhesin RadD, encouraging the intestinal mucus layer&#x2019;s bacterial biofilm formation in IBD patients. This symbiotic relationship accelerates the extracellular polysaccharides-producing process and chemotaxis level of <italic>C. difficile</italic> (<xref ref-type="bibr" rid="B37">Engevik et&#xa0;al., 2021a</xref>).</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Klebsiella</title>
<p>
<italic>Klebsiella</italic> is an opportunistic pathogen in the GI and respiratory tracts. Although a few <italic>Klebsiella</italic> physiologically colonizes in the intestine, in pathological states such as periodontitis, it demonstrates signs of ectopic colonization from the oral. Researchers found that saliva <italic>K. pneumonia</italic> of IBD patients rapidly establishes colonization in mice&#x2019;s intestines, triggering a strong inflammatory response (upregulates IFN-&#x3b3;, TH1 in the lamina propria, raises epithelial TNF-&#x3b1; mRNA expression in the proximal colon, and significantly induces IL-17, IFN-&#x3b3; and CD4<sup>+</sup> T cells level) (<xref ref-type="bibr" rid="B8">Atarashi et&#xa0;al., 2017</xref>). In mice models that were orally administrated with <italic>K. pneumoniae</italic>, the hypervirulent strain could even translocate from the intestine and lead to hepatic infections (<xref ref-type="bibr" rid="B143">Young et&#xa0;al., 2020</xref>). Th17 cell induction acts as a critical step in IBD pathogenesis and involves in regulating intestinal immunity and inflammation. Oral pathobiont-reactive Th17 cells (<italic>Klebsiella</italic> and <italic>Enterobacter</italic> species), rather than intestinal native microbes-reactive, translocate into the intestine and affect colitis progress (<xref ref-type="bibr" rid="B63">Kitamoto et&#xa0;al., 2020</xref>). Moreover, translocated <italic>Klebsiella</italic> promotes the secretion of IL-1&#x3b2; (mainly from inflammatory macrophages) <italic>via</italic> cysteine-11-mediated inflammatory vesicles, activating intestinal inflammasome (<xref ref-type="bibr" rid="B63">Kitamoto et&#xa0;al., 2020</xref>). For the intestine-native microbiome, in the <italic>K. pneumoniae</italic> infection mice model, gut microbial composition (down-regulates <italic>Lactobacillus reuteri</italic> and <italic>Bifidobacterium pseudolongum</italic>) and cecal metabolome (SCFAs) are altered (<xref ref-type="bibr" rid="B133">Wu et&#xa0;al., 2020</xref>). Whereas sufficient symbiotic microbe protection from <italic>Bacteroidetes</italic> could prevent the host-to-host transmission and intestinal colonization of <italic>K. pneumoniae via</italic> IL-36 signaling (<xref ref-type="bibr" rid="B114">Sequeira et&#xa0;al., 2020</xref>).</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Streptococcus salivarius</title>
<p>Two-group pheromone-based subsystem BlpRH is the core node coordinating bacteriocin production and integrating signals of competence activation cascade, typically for <italic>S. pneumoniae</italic> and <italic>S. mutans</italic>. Whereas human co-salivary <italic>Streptococcus</italic> lacks functional BlpRH pairs, the couples bacteriocin production and competence commitment is directly guided by the competence signaling system ComRS, which is the undetermined basis for its optimal adaptation, potentially explaining the high prevalence of <italic>S. salivarius</italic> in the human GI tract (<xref ref-type="bibr" rid="B84">Mignolet et&#xa0;al., 2018</xref>). Aside from benefiting oral health, in terms of its effect on intestinal function, the <italic>S. salivarius</italic> in the lower gastrointestinal tract is crucial for inhabiting intestinal inflammation response. It positively adjusts microbiome composition and intestinal immunity, even in healthy individuals, the predominant intestinal <italic>Streptococcus</italic> species is <italic>S. salivarius</italic> (<xref ref-type="bibr" rid="B58">Kaci et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B73">Li et&#xa0;al., 2022</xref>). It is confirmed that <italic>S. salivarius</italic> downregulates NF-&#x3ba;B pathway that triggered by LPS and inhibits peroxisome proliferator-activated receptor &#x3b3; (PPAR&#x3b3;) activation in small intestinal epithelial cells <italic>in vitro</italic> (<xref ref-type="bibr" rid="B30">Couvigny et&#xa0;al., 2015</xref>). Likewise, both mice experiment and metabolic gene sequencing (<italic>I-FABP</italic> and <italic>Angptl4</italic>, these gene products regulate intracellular lipid accumulation) revealed <italic>S. salivarius&#x2019;s</italic> protective ability to diminish intestinal epithelial inflammation (<xref ref-type="bibr" rid="B58">Kaci et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B30">Couvigny et&#xa0;al., 2015</xref>). For non-small cell lung cancer patients, <italic>S. salivarius</italic> and <italic>S. agalactiae</italic> react upon gastrointestinal-derived CD4<sup>+</sup> T cells and effectively activate monocytes to secrete higher levels of IL-6, IL-12 and TNF, or so-called, the Th1- and Th17-skewed cytokines (<xref ref-type="bibr" rid="B81">Ma et&#xa0;al., 2017</xref>). However, <italic>S. salivarius</italic> is also reported to disturb intestinal microbiota composition. Oral <italic>S. salivarius</italic> was found to be enriched and of concordant strains in both intestinal and oral microbiota in Crohn&#x2019;s disease patients, and the species diversity of the infected intestine was considerably depleted (<xref ref-type="bibr" rid="B54">Hu et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Prevotella</title>
<p>Although most <italic>Prevotella</italic> species physiologically colonize in oral and gut mucosa, a small number of <italic>Prevotella</italic> show pathobiontic properties and have been confirmed to participate in opportunistic infections. Distinct from intestinal native microbes, <italic>Prevotella</italic> owns a unique nitrogen assimilation metabolic network that rarely limits their growth. Jong Nam Kim et&#xa0;al. observed different patterns of transcript abundances in genes involving ammonium assimilation between the classical &#x201c;enteric paradigm&#x201d; and <italic>Pretovella</italic> (<xref ref-type="bibr" rid="B61">Kim et&#xa0;al., 2017</xref>). <italic>Pretovella</italic> act as a vital keystone bacterium of the gut. Binding or attaching to other bacteria and epithelium, <italic>Pretovella</italic> creates a larger infection than in previously infected areas. A higher abundance of <italic>P. intermedia</italic> and <italic>P. nigrescens</italic> (<italic>Pretovella</italic> species that are commonly resident in the oral cavity) was observed in the intestine of CRC patients (<xref ref-type="bibr" rid="B132">Wirbel et&#xa0;al., 2019</xref>). In mice experiments, oral administration of <italic>P. intermedia</italic> induces NAFLD (<xref ref-type="bibr" rid="B139">Yamazaki et&#xa0;al., 2021</xref>). In terms of IBD, <italic>Prevotella</italic> is a potential alternative biomarker for UC, tightly matched with feces and other oral areas (<xref ref-type="bibr" rid="B138">Xun et&#xa0;al., 2018</xref>). Moreover, <italic>Prevotella</italic> predominates in the intestinal microbiome in the preclinical phase of rheumatoid arthritis, promoting pathological progression in a TH17 cell-dependent manner (<xref ref-type="bibr" rid="B6">Alpizar-Rodriguez et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B80">Maeda and Takeda, 2019</xref>). In a metagenome-wide association study (MWAS) of the gut microbiome from rheumatoid arthritis patients, Toshihiro Kishikawa et&#xa0;al. identified five species that belong to the <italic>Prevotella</italic> (i.e., <italic>P. denticola, P. marshii, P. disiens, P. corporis</italic>, and <italic>P. amnii</italic>) (<xref ref-type="bibr" rid="B62">Kishikawa et&#xa0;al., 2020</xref>). Additionally, the major task for intestinal <italic>Prevotella</italic> is metabolizing various proteins and carbohydrates. Consequently, high animal protein and saturated fat diet western people own higher diversity of inflammation-associated <italic>Prevotella</italic> in the oral cavity, with intestinal microbes demonstrating upregulated virulence factor and antibiotic resistance gene levels. (<xref ref-type="bibr" rid="B99">Prasoodanan et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s4_6">
<label>4.6</label>
<title>Veillonella</title>
<p>
<italic>V. parvula</italic> is an anaerobic commensal and opportunistic pathogen that plays a crucial role in bacteria adhesion and biofilm formation for oral and gut microbiomes. Type V secreted autotransporters that typically exist in diderm bacteria determine this character. Whereas inactivation of the gene coding for a poorly characterized metal-dependent phosphohydrolase HD domain protein in <italic>Firmicutes</italic> could inhibit autotransporter-mediated biofilm formation (<xref ref-type="bibr" rid="B16">Bechon et&#xa0;al., 2020</xref>). Intestinal <italic>Veillonella</italic> attaches to the mucosa of the distal gut and positively coexists with <italic>Clostridioides</italic> in <italic>C. difficile</italic> colonization (CDC) patients (<xref ref-type="bibr" rid="B31">Crobach et&#xa0;al., 2020</xref>). Besides, it was detected the existence of <italic>Veillonella</italic> and <italic>Streptococcus</italic> in atherosclerotic plaques, whose bacterial abundances positively correlated with their abundance in the oral cavity, indicating that oral <italic>Veillonella</italic> probably spread to extraoral organs <italic>via</italic> the circulatory system (<xref ref-type="bibr" rid="B66">Koren et&#xa0;al., 2011</xref>). <italic>Veillonella</italic> extensively participates in a range of diseases associated with gastrointestinal microbial dysbiosis, for instance, hepatic and gall diseases (autoimmune hepatitis, alcoholic hepatitis, biliary atresia, and PSC) (<xref ref-type="bibr" rid="B68">Kummen et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B115">Song et&#xa0;al., 2021</xref>). Actually, <italic>Veillonella</italic> is acid-sensitive, the abundance of <italic>Veillonella</italic> heightens when aldafermin-mediated suppressions of bile acid synthesis, particularly toxic bile acids, are inhibited (<xref ref-type="bibr" rid="B77">Loomba et&#xa0;al., 2021</xref>). When regarding IBD, the enrichment of adhesive bacteria (involving <italic>Veillonella</italic>) increases Th17 cell activation and luminal secretory IgA (<xref ref-type="bibr" rid="B27">Chen et&#xa0;al., 2020a</xref>; <xref ref-type="bibr" rid="B46">Gonzalez-Soltero et&#xa0;al., 2020</xref>). In periodontitis-associated type 2 diabetes (T2D), <italic>Streptococcus</italic> and <italic>Veillonella</italic> are dominant in the symbiosis network, and microbial shifts may contribute to systemic inflammation and metabolic dysfunction (<xref ref-type="bibr" rid="B74">Li et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B72">Letchumanan et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s4_7">
<label>4.7</label>
<title>Candida albicans</title>
<p>It is almost impossible for fungi to survive in healthy people&#x2019;s intestines, and <italic>C. Albicans</italic> dominate among the cultivable mycobiota that longitudinally persists. Intestinal <italic>C. Albicans</italic> probably as commensals constantly supplemented from the oral cavity, frequent teeth cleaning dramatically reduces fecal <italic>C. Albicans</italic> abundance (<xref ref-type="bibr" rid="B9">Auchtung et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B103">Raimondi et&#xa0;al., 2019</xref>). Whereas for immunocompromised individuals, intestinal fungi and fungal molecules could result in serious infections and produce severe bacterial sepsis <italic>via</italic> cytokine storm induction or macrophage-killing activity. <italic>C. Albicans</italic> gavage worsens the colitis in mice experiments, gut-leakage induces pro-inflammatory cytokines in the intestine and blood, which was hypothesized as a more severe translocation of LPS, serum (1&#x2192;3)-&#x3b2;-D-glucan (BG) and bacteria from the gut into the systemic circulation (<xref ref-type="bibr" rid="B94">Panpetch et&#xa0;al., 2020</xref>). Regarding colonization and dissemination, in the gut, dead fungi are nutrients for bacterial fermentation. In the presence of <italic>C. Albicans</italic>, the opportunistic bacterium <italic>C. difficile</italic> can tolerate aerobic conditions, and the p-cresol produced by <italic>C. difficile</italic> inhibit <italic>C. Albian&#x2019;s</italic> hypha formation, biofilm formation, and virulence (<xref ref-type="bibr" rid="B124">van Leeuwen et&#xa0;al., 2016</xref>). This symbiotic relationship leads to more severe infection of <italic>C. difficile</italic> in mice models and increases IL-8 production in experimental intestinal epithelial cell-lines (<xref ref-type="bibr" rid="B95">Panpetch et&#xa0;al., 2019</xref>). Regarding the susceptibility to <italic>C. Albicans</italic>, <italic>C. Albicans</italic> infection could be promoted by intestinal taurocholic acid (TCA) that weakens mucosal innate and adaptive immune responses (<xref ref-type="bibr" rid="B33">Datta et&#xa0;al., 2022</xref>). Besides, the host&#x2019;s high iron level enhances <italic>C. Albicans</italic> infection severity and its dissemination from the oral to the gut (<xref ref-type="bibr" rid="B121">Tripathi et&#xa0;al., 2022</xref>). However, endogenous invasion by <italic>C. Albicans</italic> could be prevented by intestinal TLR2, and intravenous immunoglobulin (IVIg) has been proven useful for treating <italic>C. Albicans</italic> infection and maintaining intestinal homeostasis, which negatively regulates PPAR&#x3b3; and TLR-4 (<xref ref-type="bibr" rid="B100">Prieto et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B23">Charlet et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s4_8">
<label>4.8</label>
<title>Other pathogens</title>
<p>The intestinal microecological disorder is a process affecting multi-bacterial composition. In addition to common oral pathogens mentioned above, for instance, <italic>Peptostreptococcus stomatis</italic> engages in gastrointestinal cancers and is of significant centralities in the gastric carcinoma (GC) ecological network, which mediates the pathogenesis of precancerous gastric atrophy (GA) and intestinal metaplasia (IM) (<xref ref-type="bibr" rid="B29">Coker et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B134">Wu et&#xa0;al., 2022</xref>). Regarding IBD and CRC, <italic>P. stomatis</italic> is among the oral-derived biomarker panel of CRC either (<xref ref-type="bibr" rid="B144">Yu et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B93">Osman et&#xa0;al., 2021</xref>). <italic>Gemella</italic> enriches in the intestinal mucosa of IBD and CRC, while <italic>Mogibacterium</italic> is significantly more abundant in patients with adenomatous polyps (<xref ref-type="bibr" rid="B51">Hale et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B106">Rengarajan et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B10">Avuthu and Guda, 2022</xref>). Intestinal bacteriophages could communicate with gut-oral bacterial commensals, which promotes individuals&#x2019; virome profile differentiation at the early and late stages of CRC (<xref ref-type="bibr" rid="B89">Nakatsu et&#xa0;al., 2018</xref>). In terms of gastrointestinal motility disorders, a polybacterial infection (<italic>P. gingivalis</italic>, <italic>T. denticola</italic>, and <italic>Tannerella forsythia</italic>) is discovered to alter vascular and colonic BH4/nNOS/NRF2 pathways and to damage vascular relaxation and colonic motility (<xref ref-type="bibr" rid="B44">Gangula et&#xa0;al., 2015</xref>). In addition, oral lantibiotics (it has a considerable antimicrobial effect on intestinal gram-positive bacteria) produced by <italic>S. mutans</italic> decrease the diversity of intestinal microbes and reduce the abundance of <italic>Firmicutes</italic> (<xref ref-type="bibr" rid="B141">Yonezawa et&#xa0;al., 2021</xref>).</p>
</sec>
</sec>
<sec id="s5">
<label>5</label>
<title>Conclusion and perspectives</title>
<p>Growing evidence supports the associations between oral microbes and intestinal diseases. The prevalence and severity of oral diseases (e.g., periodontitis) are closely linked with the intestinal healthy state. In recent years, several intestinal pathobionts (<italic>P. gingivalis</italic>, <italic>F. nucleatum</italic>, <italic>P. intermedia</italic>, <italic>P. nigrescens</italic>, <italic>C. albicans</italic>, etc.) showed potential origin from the oral cavity <italic>via</italic> direct enteral translocation or through the circulatory system. Using deep learning algorithms, the fecal microbiome could be predicted by the oral microbiome of the same individual in a new bioinformatic tool (<xref ref-type="bibr" rid="B104">Rampelli et&#xa0;al., 2021</xref>). For enteral ectopic translocation, oral microbes have to overcome the harsh protective elements (e.g., gastric acid, bile acid, and native microbes). Consequently, the detected oral microorganisms in the lower GI tract are usually low-abundant. With the development of next-generation sequencing (NGS), the consistency between the two sites is more detectable and demonstrates further correlations than in earlier studies. In mice experiments, oral administration of oral pathobionts leads to intestinal dysbiosis, regional intestinal inflammation, and low-grade endotoxemia. Although the amount and method of intake differ from the natural state, it provides references to the possible effect of oral pathobionts on the gut, and more experiments are required to determine the species and proportion of pathobionts, the precise site of their colonization, the time of their presence, and the crosstalk with native microbes and the immune system. The circulatory system, as a channel for bacterial expansion, also facilitates the widespread dissemination of oral pathobionts. Periodontitis is generally accepted associating with systemic low-grade inflammatory diseases. The footprint of the oral-origin microbiome has been detected in extraoral organs including the heart and aortic valves. Oral microbes and their products induce immune responses <italic>via</italic> the bloodstream, which regulates the host&#x2019;s overall inflammatory state, stimulating TLR-NF-&#x3ba;B pathway or regulating TH17/Treg ratio. In addition, it is a notable phenomenon for pathogenic microbes such as <italic>F. nucleatum</italic>, <italic>C. difficile</italic>, and <italic>P. gingivalis</italic> communicating and adhering with each other. In mucosal biofilms, interspecies interactions that influence spatial organization modify microbial communities&#x2019; formation and function. Hence, it is also interesting to investigate how these oral microbes influence the survival of native microorganisms.</p>
<p>16S rRNA sequencing and conventional bacterial identification and quantification methods are suitable for identifying well-characterized and abundant genera. However, frequently using 1% as the threshold for excluding the low-abundant organisms, some oral-origin microbiome species in the intestine may escape detection unconsciously. The SourceTracker results showed that the percentage of intestinal bacteria from the tongue-coated microflora was within 1% (<xref ref-type="bibr" rid="B47">Guo et&#xa0;al., 2022</xref>). Moreover, diet and diurnal variation are independent variables that affect the composition of microbes in the GI tract, which needs further consideration while analyzing microbial communities.</p>
<p>The study of oral-gut microbes has gained popularity, not only for its role in intestinal and systemic diseases that have gradually been explored but also for its offering new approaches to conveniently detectable biomarkers and clinical therapy methods. Various probiotics, prebiotics, and even herbal medicines that work by modifying gut microbes&#x2019; variations have been proven of positive therapeutic outcomes. Both saliva and gut microbes are potential biomarkers for diagnosis. This clue indicates an overall idea to manage oral health and intestinal diseases coordinatingly in the future, and this approach is still in its infancy. As the attention to oral health grows, studying the effect of oral microbes on the intestine opens up new insight into preventing and controlling intestinal diseases and discovering new therapies.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>YL, ZL, and XP wrote and edited the manuscript. ZL and XP critically reviewed the manuscript and provided insightful discussions and ideas. YL and ZL contributed equally to this work and share first authorship. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This work is supported by grant 32070120 from the National Natural Science Foundation of China.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abed</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Maalouf</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Manson</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Earl</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Parhi</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Emgard</surname> <given-names>J. E. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Colon cancer-associated fusobacterium nucleatum may originate from the oral cavity and reach colon tumors <italic>via</italic> the circulatory system</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00400</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adel-Khattab</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Groeger</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Domann</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Lochnit</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Meyle</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>
<italic>Porphyromonas gingivalis</italic> induced up-regulation of PD-L1 in colon carcinoma cells</article-title>. <source>Mol. Oral. Microbiol.</source> <volume>36</volume> (<issue>3</issue>), <fpage>172</fpage>&#x2013;<lpage>181</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/omi.12332</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akdis</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions</article-title>? <source>Nat. Rev. Immunol.</source> <volume>21</volume> (<issue>11</issue>), <fpage>739</fpage>&#x2013;<lpage>751</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-021-00538-7</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albillos</surname> <given-names>A.</given-names>
</name>
<name>
<surname>de Gottardi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rescigno</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The gut-liver axis in liver disease: Pathophysiological basis for therapy</article-title>. <source>J. Hepatol.</source> <volume>72</volume> (<issue>3</issue>), <fpage>558</fpage>&#x2013;<lpage>577</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhep.2019.10.003</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albuquerque-Souza</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Sahingur</surname> <given-names>S. E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis</article-title>. <source>Periodontol 2000</source> <volume>89</volume> (<issue>1</issue>), <fpage>125</fpage>&#x2013;<lpage>141</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/prd.12427</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alpizar-Rodriguez</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lesker</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Gronow</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Raemy</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Lamacchia</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Prevotella copri in individuals at risk for rheumatoid arthritis</article-title>. <source>Ann. Rheum Dis.</source> <volume>78</volume> (<issue>5</issue>), <fpage>590</fpage>&#x2013;<lpage>593</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/annrheumdis-2018-214514</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanasova</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ojcius</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Nucleoside-Diphosphate-Kinase of p. gingivalis is secreted from epithelial cells in the absence of a leader sequence through a pannexin-1 interactome</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <elocation-id>37643</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep37643</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atarashi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Suda</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kawaguchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Motoo</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Narushima</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation</article-title>. <source>Science</source> <volume>358</volume> (<issue>6361</issue>), <fpage>359</fpage>&#x2013;<lpage>365</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aan4526</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auchtung</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Fofanova</surname> <given-names>T. Y.</given-names>
</name>
<name>
<surname>Stewart</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Nash</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Gesell</surname> <given-names>J. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Investigating colonization of the healthy adult gastrointestinal tract by fungi</article-title>. <source>mSphere</source> <volume>3</volume> (<issue>2</issue>), <elocation-id>e00092-18</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00092-18</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avuthu</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Guda</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Meta-analysis of altered gut microbiota reveals microbial and metabolic biomarkers for colorectal cancer</article-title>. <source>Microbiol. Spectr.</source> <volume>10</volume> (<issue>4</issue>), <elocation-id>e0001322</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.00013-22</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajaj</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Matin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>White</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Fagan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Deeb</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Acharya</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis</article-title>. <source>Am. J. Physiol. Gastrointest Liver Physiol.</source> <volume>315</volume> (<issue>5</issue>), <fpage>G824</fpage>&#x2013;<lpage>G837</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.00230.2018</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Periodontitis may induce gut microbiota dysbiosis <italic>via</italic> salivary microbiota</article-title>. <source>Int. J. Oral. Sci.</source> <volume>14</volume> (<issue>1</issue>), <fpage>32</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41368-022-00183-3</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbour</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Elebyary</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Fine</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Oveisi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Glogauer</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Metabolites of the oral microbiome: Important mediators of multikingdom interactions</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>46</volume> (<issue>1</issue>), <elocation-id>fuab039</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femsre/fuab039</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barlow</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Leite</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Romano</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Sedighi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Celly</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome</article-title>. <source>Microbiome</source> <volume>9</volume> (<issue>1</issue>), <fpage>214</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40168-021-01162-2</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baumgartner</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Holley</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Crepaz</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hausmann</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pjevac</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis</article-title>. <source>Gastroenterology</source> <volume>161</volume> (<issue>4</issue>), <fpage>1245</fpage>&#x2013;<lpage>1256.e1220</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2021.06.024</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bechon</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Jimenez-Fernandez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Witwinowski</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bierque</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Taib</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Cokelaer</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Autotransporters drive biofilm formation and autoaggregation in the diderm firmicute veillonella parvula</article-title>. <source>J. Bacteriol</source> <volume>202</volume> (<issue>21</issue>), <elocation-id>e00461-20</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00461-20</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennan</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Clay</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Lavoie</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lang</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Fonseca-Pereira</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression</article-title>. <source>Gut Microbes</source> <volume>13</volume> (<issue>1</issue>), <elocation-id>1987780</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2021.1987780</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byrd</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Gulati</surname> <given-names>A. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The "Gum-gut" axis in inflammatory bowel diseases: A hypothesis-driven review of associations and advances</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.620124</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caballero</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Pamer</surname> <given-names>E. G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Microbiota-mediated inflammation and antimicrobial defense in the intestine</article-title>. <source>Annu. Rev. Immunol.</source> <volume>33</volume>, <fpage>227</fpage>&#x2013;<lpage>256</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120238</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Fusobacterium nucleatum activates endoplasmic reticulum stress to promote crohn's disease development <italic>via</italic> the upregulation of CARD3 expression</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2020.00106</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrion</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Scisci</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Miles</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sabino</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Zeituni</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential</article-title>. <source>J. Immunol.</source> <volume>189</volume> (<issue>6</issue>), <fpage>3178</fpage>&#x2013;<lpage>3187</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1201053</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carr</surname> <given-names>V. R.</given-names>
</name>
<name>
<surname>Witherden</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shoaie</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mullany</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Proctor</surname> <given-names>G. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Abundance and diversity of resistomes differ between healthy human oral cavities and gut</article-title>. <source>Nat. Commun.</source> <volume>11</volume> (<issue>1</issue>), <fpage>693</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-14422-w</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charlet</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Sendid</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kaveri</surname> <given-names>S. V.</given-names>
</name>
<name>
<surname>Poulain</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bayry</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jawhara</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Intravenous immunoglobulin therapy eliminates candida albicans and maintains intestinal homeostasis in a murine model of dextran sulfate sodium-induced colitis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>20</volume> (<issue>6</issue>), <fpage>1473</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20061473</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>b). <article-title>Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF-kappaB <italic>via</italic> the upregulation of CARD3 expression</article-title>. <source>J. Pathol.</source> <volume>250</volume> (<issue>2</issue>), <fpage>170</fpage>&#x2013;<lpage>182</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.5358</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours <italic>via</italic> a TLR4-dependent mechanism</article-title>. <source>Cancer Immunol. Immunother.</source> <volume>67</volume> (<issue>10</issue>), <fpage>1635</fpage>&#x2013;<lpage>1646</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00262-018-2233-x</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Multi-omics insights reveal the remodeling of gut mycobiome with <italic>p. gingivalis</italic>
</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.937725</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Shu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>a). <article-title>Adhesive bacteria in the terminal ileum of children correlates with increasing Th17 cell activation</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2020.588560</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Meier</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Koestler</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>de Castillo</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Comparisons of oral, intestinal, and pancreatic bacterial microbiomes in patients with pancreatic cancer and other gastrointestinal diseases</article-title>. <source>J. Oral. Microbiol.</source> <volume>13</volume> (<issue>1</issue>), <elocation-id>1887680</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/20002297.2021.1887680</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coker</surname> <given-names>O. O.</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nakatsu</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Mucosal microbiome dysbiosis in gastric carcinogenesis</article-title>. <source>Gut</source> <volume>67</volume> (<issue>6</issue>), <fpage>1024</fpage>&#x2013;<lpage>1032</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2017-314281</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Couvigny</surname> <given-names>B.</given-names>
</name>
<name>
<surname>de Wouters</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kaci</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Jacouton</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Delorme</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Dore</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Commensal <italic>streptococcus salivarius</italic> modulates PPARgamma transcriptional activity in human intestinal epithelial cells</article-title>. <source>PloS One</source> <volume>10</volume> (<issue>5</issue>), <elocation-id>e0125371</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0125371</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crobach</surname> <given-names>M. J. T.</given-names>
</name>
<name>
<surname>Ducarmon</surname> <given-names>Q. R.</given-names>
</name>
<name>
<surname>Terveer</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Harmanus</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Sanders</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Verduin</surname> <given-names>K. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The bacterial gut microbiota of adult patients infected, colonized or noncolonized by clostridioides difficile</article-title>. <source>Microorganisms</source> <volume>8</volume> (<issue>5</issue>), <elocation-id>677</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms8050677</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D'Aiuto</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gkranias</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bhowruth</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Orlandi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Suvan</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Systemic effects of periodontitis treatment in patients with type 2 diabetes: A 12 month, single-centre, investigator-masked, randomised trial</article-title>. <source>Lancet Diabetes Endocrinol.</source> <volume>6</volume> (<issue>12</issue>), <fpage>954</fpage>&#x2013;<lpage>965</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2213-8587(18)30038-X</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Datta</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hernandez-Franco</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Olson</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>HogenEsch</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Thangamani</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Bile acid regulates mononuclear phagocytes and T helper 17 cells to control candida albicans in the intestine</article-title>. <source>J. Fungi (Basel)</source> <volume>8</volume> (<issue>6</issue>), <elocation-id>610</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof8060610</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Cena</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dame-Teixeira</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Do</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Low-abundant microorganisms: The human microbiome's dark matter, a scoping review</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.689197</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deppe</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Reitberger</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Behr</surname> <given-names>A. V.</given-names>
</name>
<name>
<surname>Vitanova</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lange</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Wantia</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Oral bacteria in infective endocarditis requiring surgery: A retrospective analysis of 134 patients</article-title>. <source>Clin. Oral. Investig.</source> <volume>26</volume> (<issue>7</issue>), <fpage>4977</fpage>&#x2013;<lpage>4985</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00784-022-04465-2</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinakaran</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Mandape</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Shuba</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Pratap</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sakhare</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Tabatabai</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Identification of specific oral and gut pathogens in full thickness colon of colitis patients: Implications for colon motility</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.03220</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engevik</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Danhof</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Auchtung</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Endres</surname> <given-names>B. T.</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Basseres</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>a). <article-title>Fusobacteriumnucleatum adheres to clostridioides difficile <italic>via</italic> the RadD adhesin to enhance biofilm formation in intestinal mucus</article-title>. <source>Gastroenterology</source> <volume>160</volume> (<issue>4</issue>), <fpage>1301</fpage>&#x2013;<lpage>1314.e1308</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2020.11.034</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engevik</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Danhof</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Engevik</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Chang-Graham</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Engevik</surname> <given-names>K. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>b). <article-title>
<italic>Fusobacterium nucleatum</italic> secretes outer membrane vesicles and promotes intestinal inflammation</article-title>. <source>mBio</source> <volume>12</volume> (<issue>2</issue>), <elocation-id>e02706-20</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.02706-20</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faith</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Guruge</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Charbonneau</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Subramanian</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Seedorf</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Goodman</surname> <given-names>A. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>The long-term stability of the human gut microbiota</article-title>. <source>Science</source> <volume>341</volume> (<issue>6141</issue>), <fpage>1237439</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1237439</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Alekseyenko</surname> <given-names>A. V.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>E. J.</given-names>
</name>
<name>
<surname>Gapstur</surname> <given-names>S. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study</article-title>. <source>Gut</source> <volume>67</volume> (<issue>1</issue>), <fpage>120</fpage>&#x2013;<lpage>127</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2016-312580</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>Y. K.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Q. L.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Y. W.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>F. Y.</given-names>
</name>
<name>
<surname>You</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Y. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Oral <italic>p. gingivalis</italic> impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice</article-title>. <source>J. Neuroinflamm.</source> <volume>17</volume> (<issue>1</issue>), <fpage>347</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12974-020-02027-5</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Figuero</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Lindahl</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Marin</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Renvert</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Herrera</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ohlsson</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Quantification of periodontal pathogens in vascular, blood, and subgingival samples from patients with peripheral arterial disease or abdominal aortic aneurysms</article-title>. <source>J. Periodontol</source> <volume>85</volume> (<issue>9</issue>), <fpage>1182</fpage>&#x2013;<lpage>1193</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1902/jop.2014.130604</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fourie</surname> <given-names>N. H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Abey</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Sherwin</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Joseph</surname> <given-names>P. V.</given-names>
</name>
<name>
<surname>Rahim-Williams</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>The microbiome of the oral mucosa in irritable bowel syndrome</article-title>. <source>Gut Microbes</source> <volume>7</volume> (<issue>4</issue>), <fpage>286</fpage>&#x2013;<lpage>301</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2016.1162363</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gangula</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Ravella</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Chukkapalli</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Rivera</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Srinivasan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hale</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Polybacterial periodontal pathogens alter vascular and gut BH4/nNOS/NRF2-phase II enzyme expression</article-title>. <source>PloS One</source> <volume>10</volume> (<issue>6</issue>), <elocation-id>e0129885</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0129885</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Alterations, interactions, and diagnostic potential of gut bacteria and viruses in colorectal cancer</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.657867</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Soltero</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Bailen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>de Lucas</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ramirez-Goercke</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Pareja-Galeano</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Larrosa</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Role of oral and gut microbiota in dietary nitrate metabolism and its impact on sports performance</article-title>. <source>Nutrients</source> <volume>12</volume> (<issue>12</issue>), <fpage>3611</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12123611</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>X. J.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X. X.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>L. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Relationships between diurnal changes of tongue coating microbiota and intestinal microbiota</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.813790</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gur</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ibrahim</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Isaacson</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Yamin</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Abed</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gamliel</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack</article-title>. <source>Immunity</source> <volume>42</volume> (<issue>2</issue>), <fpage>344</fpage>&#x2013;<lpage>355</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2015.01.010</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajishengallis</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Chavakis</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities</article-title>. <source>Nat. Rev. Immunol.</source> <volume>21</volume> (<issue>7</issue>), <fpage>426</fpage>&#x2013;<lpage>440</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-020-00488-6</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajishengallis</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Payne</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Hashim</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Jotwani</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Eskan</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement</article-title>. <source>Cell Host Microbe</source> <volume>10</volume> (<issue>5</issue>), <fpage>497</fpage>&#x2013;<lpage>506</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2011.10.006</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hale</surname> <given-names>V. L.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Harrington</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Yab</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Smyrk</surname> <given-names>T. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Shifts in the fecal microbiota associated with adenomatous polyps</article-title>. <source>Cancer Epidemiol. Biomarkers Prev.</source> <volume>26</volume> (<issue>1</issue>), <fpage>85</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-16-0337</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausmann</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Felmy</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kunz</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kroon</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Berthold</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Ganz</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Intercrypt sentinel macrophages tune antibacterial NF-kappaB responses in gut epithelial cells <italic>via</italic> TNF</article-title>. <source>J. Exp. Med.</source> <volume>218</volume> (<issue>11</issue>), <elocation-id>e20210862</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20210862</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer</article-title>. <source>Gut</source> <volume>70</volume> (<issue>11</issue>), <fpage>2123</fpage>&#x2013;<lpage>2137</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2020-322780</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Png</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Gowans</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ong</surname> <given-names>D. E. H.</given-names>
</name>
<name>
<surname>de Sessions</surname> <given-names>P. F.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Ectopic gut colonization: A metagenomic study of the oral and gut microbiome in crohn's disease</article-title>. <source>Gut Pathog.</source> <volume>13</volume> (<issue>1</issue>), <elocation-id>13</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13099-021-00409-5</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Goodrich</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Maxan</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Freedberg</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Abrams</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Poole</surname> <given-names>A. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Proton pump inhibitors alter the composition of the gut microbiota</article-title>. <source>Gut</source> <volume>65</volume> (<issue>5</issue>), <fpage>749</fpage>&#x2013;<lpage>756</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2015-310861</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ladegaard Gronkjaer</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Holmstrup</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Vilstrup</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kilian</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Unique subgingival microbiota associated with periodontitis in cirrhosis patients</article-title>. <source>Sci. Rep.</source> <volume>8</volume> (<issue>1</issue>), <fpage>10718</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-018-28905-w</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K. H.</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>C. O.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Lantibiotic-encoding streptococcus in the human microbiome are underlying risk factors for liver diseases</article-title>. <source>J. Infect.</source> <volume>84</volume> (<issue>5</issue>), <fpage>e70</fpage>&#x2013;<lpage>e72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jinf.2022.02.020</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaci</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Goudercourt</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dennin</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Pot</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dore</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ehrlich</surname> <given-names>S. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Anti-inflammatory properties of streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>80</volume> (<issue>3</issue>), <fpage>928</fpage>&#x2013;<lpage>934</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.03133-13</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashiwagi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Aburaya</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sugiyama</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Narukawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sakamoto</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>
<italic>Porphyromonas gingivalis</italic> induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>18398</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-97868-2</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yamazaki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Nakajima</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Date</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kikuchi</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hase</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Oral administration of <italic>porphyromonas gingivalis</italic> alters the gut microbiome and serum metabolome</article-title>. <source>mSphere</source> <volume>3</volume> (<issue>5</issue>), <elocation-id>e00460-18</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00460-18</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Mendez-Garcia</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Geier</surname> <given-names>R. R.</given-names>
</name>
<name>
<surname>Iakiviak</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cann</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Metabolic networks for nitrogen utilization in <italic>prevotella ruminicola</italic> 23</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>7851</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-08463-3</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishikawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Maeda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nii</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Motooka</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Matsumoto</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Matsushita</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population</article-title>. <source>Ann. Rheum Dis.</source> <volume>79</volume> (<issue>1</issue>), <fpage>103</fpage>&#x2013;<lpage>111</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/annrheumdis-2019-215743</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitamoto</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Nagao-Kitamoto</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gillilland</surname> <given-names>M. G.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Hayashi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Imai</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis</article-title>. <source>Cell</source> <volume>182</volume> (<issue>2</issue>), <fpage>447</fpage>&#x2013;<lpage>462.e414</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2020.05.048</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ogawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hashizume-Takizawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kurita-Ochiai</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Oral bacteria affect the gut microbiome and intestinal immunity</article-title>. <source>Pathog. Dis.</source> <volume>78</volume> (<issue>3</issue>), <elocation-id>ftaa024</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femspd/ftaa024</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komiya</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shimomura</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Higurashi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sugi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Arimoto</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Umezawa</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Patients with colorectal cancer have identical strains of <italic>fusobacterium nucleatum</italic> in their colorectal cancer and oral cavity</article-title>. <source>Gut</source> <volume>68</volume> (<issue>7</issue>), <fpage>1335</fpage>&#x2013;<lpage>1337</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2018-316661</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koren</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Spor</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Felin</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fak</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Stombaugh</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Tremaroli</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Human oral, gut, and plaque microbiota in patients with atherosclerosis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>108 Suppl 1</volume> (<supplement>Suppl 1</supplement>), <fpage>4592</fpage>&#x2013;<lpage>4598</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1011383107</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroese</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Brandt</surname> <given-names>B. W.</given-names>
</name>
<name>
<surname>Buijs</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Crielaard</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Lobbezoo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Loos</surname> <given-names>B. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals</article-title>. <source>Arthritis Rheumatol</source> <volume>73</volume> (<issue>11</issue>), <fpage>1986</fpage>&#x2013;<lpage>1993</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/art.41780</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kummen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Holm</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Anmarkrud</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Nygard</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vesterhus</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hoivik</surname> <given-names>M. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls</article-title>. <source>Gut</source> <volume>66</volume> (<issue>4</issue>), <fpage>611</fpage>&#x2013;<lpage>619</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2015-310500</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuraji</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Sekino</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kapila</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Numabe</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Periodontal disease-related nonalcoholic fatty liver disease and <italic>nonalcoholic steatohepatitis</italic>: An emerging concept of oral-liver axis</article-title>. <source>Periodontol 2000</source> <volume>87</volume> (<issue>1</issue>), <fpage>204</fpage>&#x2013;<lpage>240</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/prd.12387</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwong</surname> <given-names>T. N. Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Nakatsu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Tipoe</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>R. Z. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer</article-title>. <source>Gastroenterology</source> <volume>155</volume> (<issue>2</issue>), <fpage>383</fpage>&#x2013;<lpage>390.e388</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2018.04.028</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larabi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Barnich</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>H. T. T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD</article-title>. <source>Autophagy</source> <volume>16</volume> (<issue>1</issue>), <fpage>38</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15548627.2019.1635384</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Letchumanan</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Abdullah</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Marlini</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Baharom</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Lawley</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Omar</surname> <given-names>M. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Gut microbiota composition in prediabetes and newly diagnosed type 2 diabetes: A systematic review of observational studies</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.943427</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Gut microbiota and immune modulatory properties of human breast milk streptococcus salivarius and s. parasanguinis strains</article-title>. <source>Front. Nutr.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2022.798403</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gui</surname> <given-names>Q.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Periodontitis in elderly patients with type 2 diabetes mellitus: impact on gut microbiota and systemic inflammation</article-title>. <source>Aging (Albany NY)</source> <volume>12</volume> (<issue>24</issue>), <fpage>25956</fpage>&#x2013;<lpage>25980</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/aging.202174</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Autoinducer-2 of gut microbiota, a potential novel marker for human colorectal cancer, is associated with the activation of TNFSF9 signaling in macrophages</article-title>. <source>Oncoimmunology</source> <volume>8</volume> (<issue>10</issue>), <elocation-id>e1626192</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/2162402X.2019.1626192</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tay</surname> <given-names>C. Y. A.</given-names>
</name>
<name>
<surname>Octavia</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>H. K. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Genomic analysis of oral campylobacter concisus strains identified a potential bacterial molecular marker associated with active crohn's disease</article-title>. <source>Emerg. Microbes Infect.</source> <volume>7</volume> (<issue>1</issue>), <fpage>64</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41426-018-0065-6</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loomba</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ling</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Dinh</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>DePaoli</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Lieu</surname> <given-names>H. D.</given-names>
</name>
<name>
<surname>Harrison</surname> <given-names>S. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The commensal microbe veillonella as a marker for response to an FGF19 analog in NASH</article-title>. <source>Hepatology</source> <volume>73</volume> (<issue>1</issue>), <fpage>126</fpage>&#x2013;<lpage>143</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/hep.31523</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lourenvarsigmao</surname> <given-names>T. G. B.</given-names>
</name>
<name>
<surname>Spencer</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Alm</surname> <given-names>E. J.</given-names>
</name>
<name>
<surname>Colombo</surname> <given-names>A. P. V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Defining the gut microbiota in individuals with periodontal diseases: an exploratory study</article-title>. <source>J. Oral. Microbiol.</source> <volume>10</volume> (<issue>1</issue>), <elocation-id>1487741</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/20002297.2018.1487741</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Chronic stress accelerates ligature-induced periodontitis by suppressing glucocorticoid receptor-alpha signaling</article-title>. <source>Exp. Mol. Med.</source> <volume>48</volume> (<issue>3</issue>), <elocation-id>e223</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/emm.2015.127</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Takeda</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Host-microbiota interactions in rheumatoid arthritis</article-title>. <source>Exp. Mol. Med.</source> <volume>51</volume> (<issue>12</issue>), <fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-019-0283-6</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>Q. Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>D. Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X. F.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5(+)CD4(+) T cells in non-small cell lung cancer</article-title>. <source>Int. Immunopharmacol</source> <volume>52</volume>, <fpage>305</fpage>&#x2013;<lpage>309</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2017.09.024</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maki</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Kazmi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Barb</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Ames</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The oral and gut bacterial microbiomes: Similarities, differences, and connections</article-title>. <source>Biol. Res. Nurs.</source> <volume>23</volume> (<issue>1</issue>), <fpage>7</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1099800420941606</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McPherson</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Bender</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Meisel</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Systemic immunoregulatory consequences of gut commensal translocation</article-title>. <source>Trends Immunol.</source> <volume>42</volume> (<issue>2</issue>), <fpage>137</fpage>&#x2013;<lpage>150</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2020.12.005</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mignolet</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fontaine</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Sass</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nannan</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mahillon</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Coenye</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Circuitry rewiring directly couples competence to predation in the gut dweller <italic>streptococcus salivarius</italic>
</article-title>. <source>Cell Rep.</source> <volume>22</volume> (<issue>7</issue>), <fpage>1627</fpage>&#x2013;<lpage>1638</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2018.01.055</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moskovitz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nassar</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Moriel</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Cher</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Faibis</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ram</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Characterization of the oral microbiome among children with type 1 diabetes compared with healthy children</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.756808</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagao</surname> <given-names>J. I.</given-names>
</name>
<name>
<surname>Kishikawa</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Toyonaga</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Narita</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Negoro-Yasumatsu</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Pathobiont-responsive Th17 cells in gut-mouth axis provoke inflammatory oral disease and are modulated by intestinal microbiome</article-title>. <source>Cell Rep.</source> <volume>40</volume> (<issue>10</issue>), <elocation-id>111314</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2022.111314</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagata</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nishijima</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kojima</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hisada</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Imbe</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Miyoshi-Akiyama</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study</article-title>. <source>Gastroenterology</source> <volume>163</volume> (<issue>1</issue>), <fpage>222</fpage>&#x2013;<lpage>238</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2022.03.054</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakajima</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Arimatsu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Minagawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Oral administration of p. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver</article-title>. <source>PloS One</source> <volume>10</volume> (<issue>7</issue>), <elocation-id>e0134234</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0134234</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakatsu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W. K. K.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Coker</surname> <given-names>O. O.</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Alterations in enteric virome are associated with colorectal cancer and survival outcomes</article-title>. <source>Gastroenterology</source> <volume>155</volume> (<issue>2</issue>), <fpage>529</fpage>&#x2013;<lpage>541.e525</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2018.04.018</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishimura</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Fukui</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ebisutani</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nakanishi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tomita</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Role of the beta-Catenin/REG ialpha axis in the proliferation of sessile serrated Adenoma/Polyps associated with fusobacterium nucleatum</article-title>. <source>Pathogens</source> <volume>10</volume> (<issue>4</issue>), <elocation-id>434</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens10040434</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohtsu</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Takeuchi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Katagiri</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Suda</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Maekawa</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shiba</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Influence of porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice</article-title>. <source>Oral. Dis.</source> <volume>25</volume> (<issue>3</issue>), <fpage>868</fpage>&#x2013;<lpage>880</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/odi.13044</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olsen</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Yamazaki</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Can oral bacteria affect the microbiome of the gut</article-title>? <source>J. Oral. Microbiol.</source> <volume>11</volume> (<issue>1</issue>), <elocation-id>1586422</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/20002297.2019.1586422</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osman</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Neoh</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Ab Mutalib</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Chin</surname> <given-names>S. F.</given-names>
</name>
<name>
<surname>Mazlan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Raja Ali</surname> <given-names>R. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>
<italic>Parvimonas micra, peptostreptococcus stomatis, fusobacterium nucleatum</italic> and <italic>akkermansia muciniphila</italic> as a four-bacteria biomarker panel of colorectal cancer</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>2925</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-82465-0</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panpetch</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Hiengrach</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Nilgate</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tumwasorn</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Somboonna</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Wilantho</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Additional candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by lactobacillus rhamnosus L34</article-title>. <source>Gut Microbes</source> <volume>11</volume> (<issue>3</issue>), <fpage>465</fpage>&#x2013;<lpage>480</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2019.1662712</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panpetch</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Somboonna</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Palasuk</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hiengrach</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Finkelman</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tumwasorn</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Oral candida administration in a clostridium difficile mouse model worsens disease severity but is attenuated by bifidobacterium</article-title>. <source>PloS One</source> <volume>14</volume> (<issue>1</issue>), <elocation-id>e0210798</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0210798</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>B. O.</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ok</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Chun</surname> <given-names>K. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Oral-gut microbiome axis in gastrointestinal disease and cancer</article-title>. <source>Cancers (Basel)</source> <volume>13</volume> (<issue>9</issue>), <elocation-id>2124</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers13092124</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrick</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Michaud</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Gerlovin</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Signorello</surname> <given-names>L. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The oral microbiome in relation to pancreatic cancer risk in African americans</article-title>. <source>Br. J. Cancer</source> <volume>126</volume> (<issue>2</issue>), <fpage>287</fpage>&#x2013;<lpage>296</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41416-021-01578-5</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponath</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Tawk</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Barquist</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Faber</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Vogel</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>RNA Landscape of the emerging cancer-associated microbe fusobacterium nucleatum</article-title>. <source>Nat. Microbiol.</source> <volume>6</volume> (<issue>8</issue>), <fpage>1007</fpage>&#x2013;<lpage>1020</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-021-00927-7</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasoodanan</surname> <given-names>P. K. V.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Mahajan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dhakan</surname> <given-names>D. B.</given-names>
</name>
<name>
<surname>Maji</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Scaria</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Western And non-western gut microbiomes reveal new roles of prevotella in carbohydrate metabolism and mouth-gut axis</article-title>. <source>NPJ Biofilms Microbiomes</source> <volume>7</volume> (<issue>1</issue>), <fpage>77</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41522-021-00248-x</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prieto</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Carpena</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Maneu</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Gil</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Pla</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gozalbo</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>TLR2 modulates gut colonization and dissemination of candida albicans in a murine model</article-title>. <source>Microbes Infect.</source> <volume>18</volume> (<issue>10</issue>), <fpage>656</fpage>&#x2013;<lpage>660</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2016.05.005</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Priya</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Burns</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mars</surname> <given-names>R. A. T.</given-names>
</name>
<name>
<surname>Adamowicz</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Lock</surname> <given-names>E. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration</article-title>. <source>Nat. Microbiol.</source> <volume>7</volume> (<issue>6</issue>), <fpage>780</fpage>&#x2013;<lpage>795</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-022-01121-z</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y. F.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>New insights into the role of oral microbiota dysbiosis in the pathogenesis of inflammatory bowel disease</article-title>. <source>Dig Dis. Sci.</source> <volume>67</volume> (<issue>1</issue>), <fpage>42</fpage>&#x2013;<lpage>55</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10620-021-06837-2</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raimondi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Amaretti</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gozzoli</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Simone</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Righini</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Candeliere</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Longitudinal survey of fungi in the human gut: ITS profiling, phenotyping, and colonization</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.01575</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rampelli</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Fabbrini</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Candela</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Biagi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Brigidi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Turroni</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>G2S: A new deep learning tool for predicting stool microbiome structure from oral microbiome data</article-title>. <source>Front. Genet.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2021.644516</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rashidi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ebadi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Weisdorf</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Costalonga</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Staley</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>No evidence for colonization of oral bacteria in the distal gut in healthy adults</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>118</volume> (<issue>42</issue>), <elocation-id>e2114152118</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2114152118</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rengarajan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vivio</surname> <given-names>E. E.</given-names>
</name>
<name>
<surname>Parkes</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Roberson</surname> <given-names>E. D. O.</given-names>
</name>
<name>
<surname>Newberry</surname> <given-names>R. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease</article-title>. <source>Gut Microbes</source> <volume>11</volume> (<issue>3</issue>), <fpage>405</fpage>&#x2013;<lpage>420</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2019.1626683</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Rubinstein</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Friedman</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Analysis of 16S rRNA genes reveals reduced fusobacterial community diversity when translocating from saliva to GI sites</article-title>. <source>Gut Microbes</source> <volume>12</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2020.1814120</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubinstein</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Y. W.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating e-cadherin/beta-catenin signaling <italic>via</italic> its FadA adhesin</article-title>. <source>Cell Host Microbe</source> <volume>14</volume> (<issue>2</issue>), <fpage>195</fpage>&#x2013;<lpage>206</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2013.07.012</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruhlemann</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liwinski</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Heinsen</surname> <given-names>F. A.</given-names>
</name>
<name>
<surname>Bang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zenouzi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kummen</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis</article-title>. <source>Aliment Pharmacol. Ther.</source> <volume>50</volume> (<issue>5</issue>), <fpage>580</fpage>&#x2013;<lpage>589</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/apt.15375</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saboo</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Petrakov</surname> <given-names>N. V.</given-names>
</name>
<name>
<surname>Shamsaddini</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Fagan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gavis</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Sikaroodi</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning</article-title>. <source>J. Hepatol.</source> <volume>76</volume> (<issue>3</issue>), <fpage>600</fpage>&#x2013;<lpage>607</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhep.2021.11.011</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yokoji</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Aggravation of collagen-induced arthritis by orally administered porphyromonas gingivalis through modulation of the gut microbiota and gut immune system</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>6955</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-07196-7</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname> <given-names>T. S.</given-names>
</name>
<name>
<surname>Hayward</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Coelho</surname> <given-names>L. P.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Costea</surname> <given-names>P. I.</given-names>
</name>
<name>
<surname>Voigt</surname> <given-names>A. Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Extensive transmission of microbes along the gastrointestinal tract</article-title>. <source>Elife</source> <volume>8</volume>, <elocation-id>e42693</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.42693</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sender</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Fuchs</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Milo</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source>PloS Biol.</source> <volume>14</volume> (<issue>8</issue>), <elocation-id>e1002533</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.1002533</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sequeira</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>McDonald</surname> <given-names>J. A. K.</given-names>
</name>
<name>
<surname>Marchesi</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>T. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Commensal bacteroidetes protect against klebsiella pneumoniae colonization and transmission through IL-36 signalling</article-title>. <source>Nat. Microbiol.</source> <volume>5</volume> (<issue>2</issue>), <fpage>304</fpage>&#x2013;<lpage>313</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-019-0640-1</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L. Y.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z. J.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Z. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Association of gut microbiota and metabolites with disease progression in children with biliary atresia</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.698900</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanisic</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Jovanovic</surname> <given-names>M.</given-names>
</name>
<name>
<surname>George</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Homme</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Tyagi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Gut microbiota and the periodontal disease: role of hyperhomocysteinemia</article-title>. <source>Can. J. Physiol. Pharmacol.</source> <volume>99</volume> (<issue>1</issue>), <fpage>9</fpage>&#x2013;<lpage>17</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/cjpp-2020-0215</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Superdock</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Poole</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Processing method affects oral and gut microbiome composition</article-title>. <source>Curr. Developments Nutr.</source> <volume>6</volume> (<supplement>Supplement_1</supplement>), <fpage>779</fpage>&#x2013;<lpage>779</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cdn/nzac063.021</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Tangkham</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Aljahdali</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dibart</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The role of TNF-alpha induced protein 1 in the activation of pro-apoptotic proteins</article-title>. <source>Hum. Cell</source> <volume>34</volume> (<issue>4</issue>), <fpage>1123</fpage>&#x2013;<lpage>1129</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13577-021-00529-9</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Periodontitis pathogen porphyromonas gingivalis promotes pancreatic tumorigenesis <italic>via</italic> neutrophil elastase from tumor-associated neutrophils</article-title>. <source>Gut Microbes</source> <volume>14</volume> (<issue>1</issue>), <elocation-id>2073785</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2022.2073785</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tran</surname> <given-names>H. N. H.</given-names>
</name>
<name>
<surname>Hoang Thu</surname> <given-names>T. N.</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>P. H.</given-names>
</name>
<name>
<surname>Vo</surname> <given-names>C. N.</given-names>
</name>
<name>
<surname>Van Doan</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ngoc Minh</surname> <given-names>C. N.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Mucosal microbiomes and fusobacterium genomics in Vietnamese colorectal cancer patients</article-title>. <source>J. bioRxiv</source>  <volume>8</volume> (<issue>1</issue>), <fpage>87</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2022.02.25.481918</pub-id>. 2022.2002.2025.481918.</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nahar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kanaskie</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Al-Hebshi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Puri</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of candida albicans in oropharyngeal candidiasis</article-title>. <source>J. Oral. Microbiol.</source> <volume>14</volume> (<issue>1</issue>), <elocation-id>2044110</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/20002297.2022.2044110</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuzuno</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Yamada-Hara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yokoji-Takeuchi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sulijaya</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Aoki-Nonaka</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Ingestion of porphyromonas gingivalis exacerbates colitis <italic>via</italic> intestinal epithelial barrier disruption in mice</article-title>. <source>J. Periodontal Res.</source> <volume>56</volume> (<issue>2</issue>), <fpage>275</fpage>&#x2013;<lpage>288</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jre.12816</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaishnava</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Behrendt</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Ismail</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Eckmann</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hooper</surname> <given-names>L. V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>105</volume> (<issue>52</issue>), <fpage>20858</fpage>&#x2013;<lpage>20863</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0808723105</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Leeuwen</surname> <given-names>P. T.</given-names>
</name>
<name>
<surname>van der Peet</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Bikker</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Hoogenkamp</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Oliveira Paiva</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Kostidis</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Interspecies interactions between clostridium difficile and candida albicans</article-title>. <source>mSphere</source> <volume>1</volume> (<issue>6</issue>), <elocation-id>e00187-16</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00187-16</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasapolli</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Schutte</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Vital</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schomburg</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Pieper</surname> <given-names>D. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals</article-title>. <source>Gastroenterology</source> <volume>157</volume> (<issue>4</issue>), <fpage>1081</fpage>&#x2013;<lpage>1092 e1083</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2019.05.068</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velsko</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Chukkapalli</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Rivera-Kweh</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bhattacharyya</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Fusobacterium nucleatum alters atherosclerosis risk factors and enhances inflammatory markers with an atheroprotective immune response in ApoE(null) mice</article-title>. <source>PloS One</source> <volume>10</volume> (<issue>6</issue>), <elocation-id>e0129795</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0129795</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walencik</surname> <given-names>P. K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The redox-active Cu-FomA complex: the mode that provides coordination of Cu(II)/Cu(I) ions during the reduction/oxidation cycle</article-title>. <source>Dalton Trans.</source> <volume>51</volume> (<issue>40</issue>), <fpage>15515</fpage>&#x2013;<lpage>15529</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/d2dt02398a</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chiba</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Oral and gut microbial dysbiosis and non-alcoholic fatty liver disease: The central role of porphyromonas gingivalis</article-title>. <source>Front. Med. (Lausanne)</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2022.822190</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Mu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>a). <article-title>Porphyromonas gingivalis promotes colorectal carcinoma by activating the hematopoietic NLRP3 inflammasome</article-title>. <source>Cancer Res.</source> <volume>81</volume> (<issue>10</issue>), <fpage>2745</fpage>&#x2013;<lpage>2759</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-20-3827</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Y. H.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>Z. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>b). <article-title>Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors</article-title>. <source>Int. J. Cancer</source>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.33596</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Dou</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Is oral microbiome of children able to maintain resistance and functional stability in response to short-term interference of ingesta</article-title>? <source>Protein Cell</source> <volume>12</volume> (<issue>6</issue>), <fpage>502</fpage>&#x2013;<lpage>510</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13238-020-00774-y</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wirbel</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Pyl</surname> <given-names>P. T.</given-names>
</name>
<name>
<surname>Kartal</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Zych</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kashani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Milanese</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer</article-title>. <source>Nat. Med.</source> <volume>25</volume> (<issue>4</issue>), <fpage>679</fpage>&#x2013;<lpage>689</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41591-019-0406-6</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Alterations in the gut microbiome and cecal metabolome during klebsiella pneumoniae-induced pneumosepsis</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01331</pub-id>
</citation>
</ref>
<ref id="B134">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Oral and gastric microbiome in relation to gastric intestinal metaplasia</article-title>. <source>Int. J. Cancer</source> <volume>150</volume> (<issue>6</issue>), <fpage>928</fpage>&#x2013;<lpage>940</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.33848</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>Y. W.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study</article-title>. <source>Cancer Lett.</source> <volume>499</volume>, <fpage>201</fpage>&#x2013;<lpage>208</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.canlet.2020.11.030</pub-id>
</citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>L. H.</given-names>
</name>
<name>
<surname>He</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Zhen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: Pooled analysis of 3 prospective cohorts</article-title>. <source>Gastroenterology</source> <volume>161</volume> (<issue>6</issue>), <fpage>1842</fpage>&#x2013;<lpage>1852.e1810</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2021.08.005</pub-id>
</citation>
</ref>
<ref id="B137">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of fusobacterium nucleatum in THP-1-derived macrophages</article-title>. <source>Cell Death Dis.</source> <volume>9</volume> (<issue>3</issue>), <fpage>355</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-018-0389-0</pub-id>
</citation>
</ref>
<ref id="B138">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xun</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profiles</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.01136</pub-id>
</citation>
</ref>
<ref id="B139">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamazaki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tsuboi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Miyauchi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Suda</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Oral pathobiont-induced changes in gut microbiota aggravate the pathology of nonalcoholic fatty liver disease in mice</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.766170</pub-id>
</citation>
</ref>
<ref id="B140">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease <italic>via</italic> ferroptosis</article-title>. <source>Microbes Infect.</source> <volume>25</volume> (<issue>1-2</issue>), <fpage>105040</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micinf.2022.105040</pub-id>
</citation>
</ref>
<ref id="B141">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yonezawa</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Motegi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Oishi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hojo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Higashi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Nozaki</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Lantibiotics produced by oral inhabitants as a trigger for dysbiosis of human intestinal microbiota</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>7</issue>), <elocation-id>3343</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22073343</pub-id>
</citation>
</ref>
<ref id="B142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshihara</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kioi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Baba</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Usuda</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kessoku</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Iwaki</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A prospective interventional trial on the effect of periodontal treatment on fusobacterium nucleatum abundance in patients with colorectal tumours</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>23719</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-03083-4</pub-id>
</citation>
</ref>
<ref id="B143">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Bray</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Nagpal</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Caudell</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Yadav</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zafar</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Animal model to study klebsiella pneumoniae gastrointestinal colonization and host-to-Host transmission</article-title>. <source>Infect. Immun.</source> <volume>88</volume> (<issue>11</issue>), <elocation-id>e00071-20</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00071-20</pub-id>
</citation>
</ref>
<ref id="B144">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Q. Y.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer</article-title>. <source>Gut</source> <volume>66</volume> (<issue>1</issue>), <fpage>70</fpage>&#x2013;<lpage>78</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2015-309800</pub-id>
</citation>
</ref>
<ref id="B145">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The effects of porphyromonas gingivalis on atherosclerosis-related cells</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.766560</pub-id>
</citation>
</ref>
<ref id="B146">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Nicolls</surname> <given-names>M. R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Colorectal cancer-associated microbiome patterns and signatures</article-title>. <source>Front. Genet.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2021.787176</pub-id>
</citation>
</ref>
<ref id="B147">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>ANGPTL4-mediated promotion of glycolysis facilitates the colonization of fusobacterium nucleatum in colorectal cancer</article-title>. <source>Cancer Res.</source> <volume>81</volume> (<issue>24</issue>), <fpage>6157</fpage>&#x2013;<lpage>6170</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-21-2273</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>